ライブラリ登録: Guest
Critical Reviews™ in Immunology

年間 6 号発行

ISSN 印刷: 1040-8401

ISSN オンライン: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Inflammation, NF-κB, and Chronic Diseases: How are They Linked?

巻 40, 発行 1, 2020, pp. 1-39
DOI: 10.1615/CritRevImmunol.2020033210
Get accessGet access

要約

Most chronic diseases, caused by lifestyle factors, appear to be linked to inflammation. Inflammation is activated mechanistically, and nuclear factor-κB (NF-κB) is a significant mediator. NF-κB, one of the most studied transcription factors, was first identified in the nucleus of B lymphocytes almost three decades ago. This protein has a key function in regulating the human immune system, and its dysregulation has been linked to many chronic diseases including asthma, cancer, diabetes, rheumatoid arthritis, inflammation, and neurological disorders. Physiologically, many cytokines have been discovered that activate NF-κB. Pathologically, environmental carcinogens such as cigarette smoke, radiation, bacteria, and viruses can also activate this transcription factor. NF-κB activation controls expression of more than 500 genes, and most are deleterious to the human body when dysregulated. More than 70,000 articles have been published regarding NF-κB. This review emphasizes the upside and downside of NF-κB in normal and disease conditions and the ways in which we can control this critical transcription factor in patients.

参考
  1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801. .

  2. Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB. Chronic diseases, inflammation, and spices: how are they linked? J Transl Med. 2018 Jan 25;16(1):14. .

  3. Parkin J, Cohen B. An overview of the immune system. Lancet. 2001 Jun 2;357(9270):1777-89. .

  4. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771-6. .

  5. Barton GM. A calculated response: control of inflammation by the innate immune system. J Clin Invest. 2008 Feb;118(2):413-20. .

  6. Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB. Inflammation, a double-edge sword for cancer and other age-related diseases. Front Immunol. 2018;9:2160. .

  7. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-20. .

  8. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1p generation. Clin Exp Immunol. 2007;147(2):227-35. .

  9. Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev. 2000;177:68-78. .

  10. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017; 9(6):7204-18. .

  11. Zhou Y, Hong Y, Huang H. Triptolide attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-KB signaling pathway. Kidney Blood Press Res. 2016;41(6):901-10. .

  12. Cavaillon JM. Contribution of cytokines to inflammatory mechanisms. Pathol Biol (Paris). 1993;41(8 Pt 2): 799-811. .

  13. Lawrence T. The nuclear factor NF-KB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1(6):a001651. .

  14. Xie WR, Deng H, Li H, Bowen TL, Strong JA, Zhang JM. Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience. 2006;142(3):809-22. .

  15. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27-37. .

  16. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975;72(9):3666-70. .

  17. Aggarwal BB, Aiyer RA, Pennica D, Gray PW, Goeddel DV. Human tumour necrosis factors: structure and receptor interactions. Ciba Found Symp. 1987;131:39-51. .

  18. Aggarwal BB. Comparative analysis of the structure and function of TNF-a and TNF-p. Immunol Ser. 1992;56:61-78. .

  19. Aggarwal BB. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-KB. Ann Rheum Dis. 2000 Nov;59(Suppl 1):i6-16. .

  20. Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. Cytokine research in depression: principles, chal-lenges, and open questions. Front Psychiatry. 2019;10:30. .

  21. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-From molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754(1-2):253-62. .

  22. Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010;140(6):935-50. .

  23. Monastero RN, Pentyala S. Cytokines as biomarkers and their respective clinical cutoff levels. Int J Inflam. 2017;2017:4309485. .

  24. Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care. 2010;13(5):541-7. .

  25. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124(4):823-35. .

  26. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-a induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 1997;81(1):255-62. .

  27. Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001;21(14):5027-35. .

  28. Copray JC, Mantingh I, Brouwer N, Biber K, Kust BM, Liem RS, Huitinga I, Tilders FJ, Van Dam AM, Boddeke HW. Expression of interleukin-1P in rat dorsal root ganglia. J Neuroimmunol. 2001;118(2):203-11. .

  29. Zhang JM, Li H, Liu B, Brull SJ. Acute topical application of tumor necrosis factor a evokes protein kinase A-dependent responses in rat sensory neurons. J Neurophysiol. 2002;88(3):1387-92. .

  30. White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, Miller RJ. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci. 2005;102(39):14092-7. .

  31. Ozaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asik I, DeLeo JA, Weinstein JN. Effects of interleukin-1 P, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J. 2006;15(10):1529-37. .

  32. Sun JH, Yang B, Donnelly DF, Ma C, LaMotte RH. MCP-1 Enhances the excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol. 2006;96(5):2189-99. .

  33. Sethi G, Sung B, Kunnumakkara AB, Aggarwal BB. Targeting TNF for treatment of cancer and autoimmunity. Adv Exp Med Biol. 2009;647:37-51. .

  34. Maier SF, Wiertelak EP, Martin D, Watkins LR. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 1993;623(2):321-4. .

  35. Thakur KK, Saini J, Mahajan K, Singh D, Jayswal DP, Mishra S, Bishayee A, Sethi G, Kunnumakkara AB. Therapeutic implications of toll-like receptors in peripheral neuropathic pain. Pharmacol Res. 2017;115:224-232. .

  36. Hirota H, Kiyama H, Kishimoto T, Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med. 1996;183(6):2627-34. .

  37. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int. 2004;45(2-3):389-95. .

  38. Ghosh S, Karin M. Missing pieces in the NF-KB puzzle. Cell. 2002;109(Suppl):S81-96. .

  39. Liu T, Zhang L, Joo D, Sun SC. NF-KB Signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. .

  40. Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann NY Acad Sci. 2014;1319:82-95. .

  41. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. .

  42. Tak PP, Firestein GS. NF-KB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7-11. .

  43. Karin M, Yamamoto Y, Wang QM. The IKK NF-KB system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3(1):17-26. .

  44. Baltimore D. Discovering NF-KB. Cold Spring Harb Perspect Biol. 2009;1(1):a000026. .

  45. Sun SC, Chang JH, Jin J. Regulation of nuclear factor-KB in autoimmunity. Trends Immunol. 2013;34(6):282-9. .

  46. Karin M, Greten FR. NF-KB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749-59. .

  47. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705-16. .

  48. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, Weissman S, Snyder M. Distribution of NF-KB-binding sites across human chromosome 22. Proc Natl Acad Sci. 2003;100(21):12247-52. .

  49. Sun SC. Non-canonical NF-KB signaling pathway. Cell Res. 2011;21(1):71-85. .

  50. Baldwin Jr AS. The NF-KB and IKB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-83. .

  51. Ghosh S, May MJ, Kopp EB. NF-KB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-60. .

  52. Oeckinghaus A, Ghosh S. The NF-KB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4):a000034. .

  53. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-KB signaling module. Oncogene. 2006;25(51):6706-16. .

  54. Hayden MS, West AP, Ghosh S. NF-KB and the immune response. Oncogene. 2006;25(51):6758-80. .

  55. Pettit AR, Quinn C, MacDonald KP, Cavanagh LL, Thomas G, Townsend W, Handel M, Thomas R. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J Immunol. 1997;159(8):3681-91. .

  56. O'Sullivan BJ, MacDonald KP, Pettit AR, Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci. 2000;97(21):11421-6. .

  57. Yilmaz ZB, Weih DS, Sivakumar V, Weih F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 2003 Jan 2;22(1):121-30. .

  58. Chatterjee B, Roy P, Sarkar UA, Zhao M, Ratra Y, Singh A, Chawla M, De S, Gomes J, Sen R, Basak S. immune differentiation regulator p100 tunes NF-KB responses to TNF. Front Immunol. 2019 May 7;10:997. .

  59. Hernandez A, Burger M, Blomberg BB, Ross WA, Gaynor JJ, Lindner I, Cirocco R, Mathew JM, Carreno M, Jin Y, Lee KP, Esquenazi V, Miller J. inhibition of NF-KB during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches. Hum Immunol. 2007;68(9):715-29. .

  60. Rothwarf DM, Karin M. The NF-KB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE. 1999;1999(5):RE1. .

  61. Boisson B, Puel A, Picard C, Casanova JL. Human iKBa gain of function: a severe and syndromic immunodeficiency. J Clin Immunol. 2017 Jul;37(5):397-412 .

  62. Scheidereit C. IKB Kinase complexes: gateways to NF-KB activation and transcription. Oncogene. 2006; 25(51):6685-705. .

  63. Gilmore TD, Wolenski FS. NF-KB: where did it come from and why? Immunol Rev. 2012;246(1):14-35. .

  64. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of iKB-a proteolysis by site-specific, signal-induced phosphorylation. Science. 1995;267(5203):1485-8. .

  65. Nakagawa MM, Chen H, Rathinam CV. Constitutive activation of NF-KB pathway in hematopoietic stem cells causes loss of quiescence and deregulated transcription factor networks. Front Cell Dev Biol. 2018;6:143. .

  66. Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015 Dec;26(6):673-85. .

  67. Courtois G, Gilmore TD. Mutations in the NF-KB signaling pathway: implications for human disease. Oncogene. 2006;25(51):6831-43. .

  68. Putnam NH, Srivastava M, Hellsten U, Dirks B, Chapman J, Salamov A, Terry A, Shapiro H, Lindquist E, Kapitonov VV, Jurka J, Genikhovich G, Grigoriev IV, Lucas SM, Steele RE, Finnerty JR, Technau U, Martindale MQ, Rokhsar DS. Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization. Science. 2007;317(5834):8-94. .

  69. Sullivan JC, Kalaitzidis D, Gilmore TD, Finnerty JR. Rel Homology domain-containing transcription factors in the cnidarian Nematostella vectensis. Dev Genes Evol. 2007;217(1):63-72. .

  70. Hatada EN, Krappmann D, Scheidereit C. NF-KB and The innate immune response. Curr Opin Immunol. 2000; 12(1):52-8. .

  71. Astarci E, Sade A, Cimen I, Savas B, Banerjee S. The NF-KB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells. FEBS J. 2012;279(16):2966-86. .

  72. Gerondakis S, Siebenlist U. Roles of the NF-KB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol. 2010;2(5):a000182. .

  73. Bottero V, Withoff S, Verma IM. NF-KB and the regulation of hematopoiesis. Cell Death Differ. 2006;13(5):785-97. .

  74. Cildir G, Low KC, Tergaonkar V. Noncanonical NF-KB signaling in health and disease. Trends Mol Med. 2016;22(5):414-29. .

  75. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6(2):93-106. .

  76. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8(4):290-301. .

  77. Trumpp A, Essers M, Wilson A. Awakening dormant haematopoietic stem cells. Nat Rev Immunol. 2010; 10(3):201-9. .

  78. Baldridge MT, King KY, Goodell MA. inflammatory signals regulate hematopoietic stem cells. Trends Immunol. 2011;32(2):57-65. .

  79. King KY, Goodell MA. inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol. 2011;11(10):685-92. .

  80. Mirantes C, Passegue E, Pietras EM. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res. 2014;329(2):248-54. .

  81. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A. IFNa Activates dormant haematopoietic stem cells in vivo. Nature. 2009;458(7240):904-8. .

  82. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. interferon regulatory factor-2 protects quiescent hema-topoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009;15(6):696-700. .

  83. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-y in response to chronic infection. Nature. 2010;465(7299):793-7. .

  84. Ghosh S, Hayden MS. New regulators of NF-KB in in-flammation. Nat Rev Immunol. 2008;8(11):837-48. .

  85. Vallabhapurapu S, Karin M. Regulation and function of NF-KB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693-733. .

  86. Jimi E, Ghosh S. Role of nuclear factor-KB in the immune system and bone. Immunol Rev. 2005;208:80-7. .

  87. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I. NF-KB regulation in human neutrophils by nuclear IKBa: correlation to apoptosis. J Immunol. 2002;169(7):3947-53. .

  88. Martin E, O'Sullivan B, Low P, Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 2003;18(1):155-67. .

  89. Dorrington MG, Fraser IDC. NF-KB Signaling in macro-phages: dynamics, crosstalk, and signal integration. Front Immunol. 2019;10:705. .

  90. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U. Requirement for NF-KB in osteoclast and B-cell development. Genes Dev. 1997;11(24):3482-96. .

  91. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 2000;19(23):6351-60. .

  92. Goldmit M, Ji Y, Skok J, Roldan E, Jung S, Cedar H, Bergman Y. Epigenetic ontogeny of the Igk locus during B cell development. Nat Immunol. 2005;6(2):198-203. .

  93. Schauer SL, Bellas RE, Sonenshein GE. Dominant signals leading to inhibitor KB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J Immunol. 1998;160(9):4398-405. .

  94. Hayden MS, Ghosh S. Shared principles in NF-KB signaling. Cell. 2008;132(3):344-62. .

  95. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995;9(16):1965-77. .

  96. Grumont RJ, Strasser A, Gerondakis S. B Cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-KB regulated c-myc transcription. Mol Cell. 2002;10(6):1283-94. .

  97. Grumont R, Lock P, Mollinari M, Shannon FM, Moore A, Gerondakis S. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-KB-dependent c-myc expression. Immunity. 2004;21:19-30. .

  98. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, Banerjee A. Unravelling the complexities of the NF-KB signalling pathway using mouse knockout and transgenic models. Oncogene. 2006;25(51):6781-99. .

  99. Sriskantharajah S, Belich MP, Papoutsopoulou S, Janzen J, Tybulewicz V, Seddon B, Ley SC. Proteolysis of NF-KB1 p105 is essential for T cell antigen receptor-induced pro-liferation. Nat Immunol. 2009;10(1):38-47. .

  100. Baeuerle PA, Baichwal VR. NF-KB As a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111-37. .

  101. Ghosh S, May MJ, Kopp EB. NF-KB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-60. .

  102. Janeway Jr CA, Medzhitov R. Lipoproteins take their toll on the host. Curr Biol. 1999;9(23):R879-82. .

  103. Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol. 2000;12(1):13-9. .

  104. Zhang G, Ghosh S. Toll-like receptor-mediated NF-KB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001;107(1):13-9. .

  105. Dev A, Iyer S, Razani B, Cheng G. NF-KB and Innate immunity. Curr Top Microbiol Immunol. 2011;349:115-43. .

  106. Jiang B, Zhang R, Pei DW. In GM-CSF restrain mitochondria pathway apoptosis, NF-KB is not the only way. Blood. 2006;108(11):4226. .

  107. Johnson RW. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci. 1997; 75(5):1244-55. .

  108. Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci. 2011;3(1):118-27. .

  109. Eckersall PD, Conner JG. Bovine and canine acute phase proteins. Vet Res Commun. 1988;12(2-3):169-78. .

  110. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990;7(2):147-59. .

  111. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol. 1994;6(4):584-9. .

  112. Pahl HL. Activators and target genes of Rel/NF-KB transcription factors. Oncogene. 1999;18(49):6853-66. .

  113. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schroder JM, Stange EF. NF-KB- and AP-1-mediated induction of human P de- fensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun. 2004;72(10):5750-8. .

  114. Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M, Liu JG, Pei XH, Wang LJ, Lin ZX, Gupta K, Mackman N, Slungaard A, Key NS, Geng JG. NF-KB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem. 2009;284(7):4473-83. .

  115. Zhao Y, Feng G, Wang Y, Yue Y, Zhao W. A key mediator, PTX3, of IKK/IKB/NF-KB exacerbates human umbilical vein endothelial cell injury and dysfunction. Int J Clin Exp Pathol. 2014;7(11):7699-707. .

  116. Li X, Massa PE, Hanidu A, Peet GW, Aro P, Savitt A, Mische S, Li J, Marcu KB. IKKa, IKKP, and NEMO/ IKKy are each required for the NF-KB-mediated inflammatory response program. J Biol Chem. 2002;277(47): 45129-40. .

  117. Zheng Z, Li Z, Chen S, Pan J, Ma X. Tetramethylpyrazine attenuates TNF-a-induced iNOS expression in human endothelial cells: involvement of Syk-mediated activation of PI3K-IKK-IKB signaling pathways. Exp Cell Res. 2013;319(14):2145-51. .

  118. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of the human P-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163(12):6718-24. .

  119. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM. Mucoid Pseudomonas aeruginosa, TNF-a, and IL-1P, but not IL-6, induce human P-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol. 2000;22(6):714-21. .

  120. Mackman N. Regulation of the tissue factor gene. Thromb Haemost. 1997;78(1):747-54. .

  121. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005; 3(8):1590-6. .

  122. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106(5):1604-11. .

  123. Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost. 2006;32(1):5-10. .

  124. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a KB-like site. Mol Cell Biol. 1994;14(6):3772-81. .

  125. Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344(14):1058-66. .

  126. Brodeur SR, Angelini F, Bacharier LB, Blom AM, Mizoguchi E, Fujiwara H, Plebani A, Notarangelo LD, Dahlback B, Tsitsikov E, Geha RS. C4b-Binding protein (C4BP) activates B cells through the CD40 receptor. Immunity. 2003;18(6):837-48. .

  127. Blom AM, Villoutreix BO, Dahlback B. Complement inhibitor C4b-binding protein: friend or foe in the innate immune system? Mol Immunol. 2004;40(18):1333-46. .

  128. Ahmed-Choudhury J, Russell CL, Randhawa S, Young LS, Adams DH, Afford SC. Differential induction of nuclear factor-KB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol Biol Cell. 2003;14(4):1334-45. .

  129. Chen CC, Manning AM. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-KB. Agents Actions Suppl. 1995;47:135-41. .

  130. Kopp EB, Ghosh S. NF-KB and Rel proteins in innate immunity. Adv Immunol. 1995;58:1-27. .

  131. Wissink S, van de Stolpe A, Caldenhoven E, Koenderman L, van der Saag PT. NF-KB/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Im munobiology. 1997;198(1-3):50-64. .

  132. Singh A, Ni J, Aggarwal BB. Death domain receptors and their role in cell demise. J Interferon Cytokine Res. 1998 Jul;18(7):439-50. .

  133. Arias-Salvatierra D, Silbergeld EK, Acosta-Saavedra LC, Calderon-Aranda ES. Role of nitric oxide produced by iNOS through NF-KB pathway in migration of cerebellar granule neurons induced by lipopolysaccharide. Cell Signal. 2011;23(2):425-35. .

  134. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF)-KB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor a-induced apoptosis. J Exp Med. 1998;188(1):211-6. .

  135. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Bald-win Jr AS. NF-KB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281(5383):1680-3. .

  136. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, An apoptosis inhibitor involved in NF-KB-mediated cell survival. Science. 1998;281(5379):998-1001. .

  137. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcrip-tional target of NF-KB that blocks TNFa-induced apoptosis. Genes Dev. 1999;13(4):382-7. .

  138. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent in-duction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 1999 Feb 15;13(4):400-11. .

  139. Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W, Schmitz ML. The pro- or anti-apoptotic function of NF-KB is determined by the nature of the apoptotic stimulus. Eur J Biochem. 2000 Jun;267(12):3828-35. .

  140. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel AE. The NF-KB cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol. 2000;165(4):1743-54. .

  141. Bui NT, Livolsi A, Peyron JF, Prehn JH. Activation of nuclear factor KB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IKB a. J Cell Biol. 2001;152(4):753-64. .

  142. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-KB signals induce the expression of c-FLIP. Mol Cell Biol. 2001;21(16):5299-305. .

  143. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. Induction of gadd45p by NF-KB downregulates pro-apoptotic JNK signalling. Nature. 2001;414(6861):308-13. .

  144. Mistry P, Deacon K, Mistry S, Blank J, Patel R. NF-KB promotes survival during mitotic cell cycle arrest. J Biol Chem. 2004;279(2):1482-90. .

  145. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-KB. Cancer Res. 1998 Mar 1;58(5):882-6. .

  146. Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP. Nuclear factor-KB, cancer, and apoptosis. Biochem Pharmacol. 2000 Oct 15;60(8):1085-9. .

  147. Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-KB in cell growth regulation. Am J Pathol. 2001;159(2):387-97. .

  148. Bash J, Zong WX, Gelinas C. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol Cell Biol. 1997 Nov;17(11):6526-36. .

  149. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Bald-win Jr AS. NF-KB Controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 1999;19(8):5785-99. .

  150. Ledoux AC, Perkins ND. NF-KB and the cell cycle. Biochem Soc Trans. 2014 Feb;42(1):76-81. .

  151. Xia YF, Liu LP, Zhong CP, Geng JG. NF-KB Activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. Biochem Biophys Res Commun. 2001 Dec 14;289(4):851-6. .

  152. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-KB and cytokine-inducible enhancers. FASEB J. 1995 Jul;9(10):899-909. .

  153. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-KB site and p65 homodimers. J Biol Chem. 1995 Jan 13;270(2):933-43. .

  154. Whelan J, Ghersa P, Hooft van Huijsduijnen R, Gray J, Chandra G, Talabot F, DeLamarter JF. An NF KB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 1991 May 25;19(10):2645-53. .

  155. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 1992 Dec 1;176(6):1583-93. .

  156. Hooft van Huijsduijnen R, Whelan J, Pescini R, Becker-Andre M, Schenk AM, DeLamarter JF. A T-cell enhancer cooperates with NF-KB to yield cytokine induction of E-selectin gene transcription in endothelial cells. J Biol Chem. 1992 Nov 5;267(31):22385-91. .

  157. Schindler U, Baichwal VR. Three NF-KB binding sites in the human E-selectin gene required for maximal tumor necrosis factor a-induced expression. Mol Cell Biol. 1994 Sep;14(9):5820-31. .

  158. Blackwell TS, Christman JW. The role of nuclear factor-KB in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997;17(1):3-9. .

  159. Monisha J, Padmavathi G, Roy NK, Deka A, Bordoloi D, Anip A, Kunnumakkara AB. NF-KB blockers gifted by mother nature: prospectives in cancer cell chemosensitization. Curr Pharm Des. 2016;22(27):4173-200. .

  160. Schreck R, Baeuerle PA. NF-KBAS inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol Cell Biol. 1990;10(3):1281-6. .

  161. Manna SK, Ramesh GT. Interleukin-8 induces nuclear transcription factor-KB through a TRAF6-dependent path-way. J Biol Chem. 2005;280(8):7010-21. .

  162. Brasier AR. The nuclear factor-KB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 2010;86(2):211-8. .

  163. Pfeffer LM. The role of nuclear factor KB in the interferon response. J Interferon Cytokine Res. 2011;31(7):553-9. .

  164. Hayden MS, Ghosh S. Regulation of NF-KB by TNF family cytokines. Semin Immunol. 2014;26(3):253-66. .

  165. Meng Q, Cooney M, Yepuri N, Cooney RN. L-Arginine attenuates interleukin-1p (IL-1P) induced nuclear factor-Kp (NF-KB) activation in Caco-2 cells. PLoS One. 2017;12(3):e0174441. .

  166. Sun SC. The noncanonical NF-KB pathway. Immunol Rev. 2012;246(1):125-40. .

  167. Yang CH, Wei L, Pfeffer SR, Du Z, Murti A, Valentine WJ, Zheng Y, Pfeffer LM. Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol. 2007;178(2):986-92. .

  168. Pandey MK, Gupta SC, Nabavizadeh A, Aggarwal BB. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment. Semin Cancer Biol. 2017 Oct;46:158-81. .

  169. Zordoky BN, El-Kadi AO. Role of NF-KB in the regulation of cytochrome P450 enzymes. Curr Drug Metab. 2009;10(2):164-78. .

  170. Candido S, Maestro R, Polesel J, Catania A, Maira F, Signorelli SS, McCubrey JA, Libra M. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer. Oncotarget. 2014;5(6):1576-94. .

  171. Manea SA, Constantin A, Manda G, Sasson S, Manea A. Regulation of Nox enzymes expression in vascular pathophysiology: focusing on transcription factors and epigenetic mechanisms. Redox Biol. 2015;5:358-66. .

  172. Stavropoulou E, Pircalabioru GG, Bezirtzoglou E. The role of cytochromes P450 in infection. Front Immunol. 2018;9:89. .

  173. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci. 2004;101(29):10679-84. .

  174. Clark RA, Valente AJ. Nuclear factor KB activation by NADPH oxidases. Mech Ageing Dev. 2004; 125(10-11):799-810. .

  175. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10(4):416-21. .

  176. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005;115(11):3149-56. .

  177. Zangar RC, Bollinger N, Verma S, Karin NJ, Lu Y. The nuclear factor-KB pathway regulates cytochrome P450 3A4 protein stability. Mol Pharmacol. 2008;73(6):1652-8. .

  178. Wolfram S, Teupser D, Tan M, Chen KY, Breslow JL. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-KB target genes. Proc Natl Acad Sci. 2007;104(47):18601-6. .

  179. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immuno-pathology. Trends Immunol. 2009;30(8):383-91. .

  180. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-KB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114(4):569-81. .

  181. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY. NF-KB In breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med. 2007;13(1):62-9. .

  182. Narasimhan M, Ammanamanchi S. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Cancer Res. 2008;68(13):5185-92. .

  183. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281-319. .

  184. Winkles JA. Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog Nucleic Acid Res Mol Biol. 1998;58:41-78. .

  185. Fowler T, Sen R, Roy AL. Regulation of primary response genes. Mol Cell. 2011 Nov 4;44(3):348-60. .

  186. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984 Oct 4-10;311(5985):433-8. .

  187. Tullai JW, Schaffer ME, Mullenbrock S, Sholder G, Kasif S, Cooper GM. Immediate-early and delayed primary response genes are distinct in function and genomic architecture. J Biol Chem. 2007 Aug 17;282(33): 23981-95. .

  188. Serrat N, Sebastian C, Pereira-Lopes S, Valverde-Estrella L, Lloberas J, Celada A. The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPp. J Immunol. 2014 Jan 1;192(1):418-26. .

  189. Bahrami S, Drablos F. Gene regulation in the imme-diate-early response process. Adv Biol Regul. 2016 Sep;62:37-49. .

  190. Chapman NR, Perkins ND. Inhibition of the RelA(p65) NF-KB subunit by Egr-1. J Biol Chem. 2000 Feb 18; 275(7):4719-25. .

  191. Subramaniam M, Hawse JR, Bruinsma ES, Grygo SB, Cicek M, Oursler MJ, Spelsberg TC. TGFP Inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun. 2010 Jan 29;392(1):72-6. .

  192. Hawse JR, Cicek M, Grygo SB, Bruinsma ES, Rajamannan NM, van Wijnen AJ, Lian JB, Stein GS, Oursler MJ, Subramaniam M, Spelsberg TC. TIEG1/KLF10 Modulates Runx2 expression and activity in osteoblasts. PLoS One. 2011 Apr 29;6(4):e19429. .

  193. Souri Z, Wierenga APA, Van Weeghel C, Van der Velden PA, Kroes WGM, Luyten GPM, Van der Burg SH, Jochemsen AG, Jager MJ. Loss of BAP1 is associated with upregulation of the NFKB pathway and increased HLA class I expression in uveal melanoma. Cancers (Basel). 2019 Aug 2;11(8):1102. .

  194. Kuo MT, Liu Z, Wei Y, Lin-Lee YC, Tatebe S, Mills GB, Unate H. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-KB signaling. Oncogene. 2002;21(13):1945-54. .

  195. Fantuzzi L, Spadaro F, Vallanti G, Canini I, Ramoni C, Vicenzi E, Belardelli F, Poli G, Gessani S. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood. 2003;102(7):2334-7. .

  196. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V. NF-KB tran-scription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene. 2003;22(1):90-7. .

  197. Kawai T, Akira S. Signaling to NF-KB by Toll-like receptors. Trends Mol Med. 2007;13(11):460-9. .

  198. Hermonat PL, Zhu H, Cao M, Mehta JL. LOX-1 transcription. Cardiovasc Drugs Ther. 2011;25(5):393-400. .

  199. Shostak K, Chariot A. EGFR and NF-KB: partners in cancer. Trends Mol Med. 2015;21(6):385-93. .

  200. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010 Dec 1;49(11):160316. .

  201. Iwanaszko M, Kimmel M. NF-KB and IRF Pathways: cross-regulation on target genes promoter level. BMC Genomics. 2015 Apr 17;16:307. .

  202. David A, Arnaud N, Fradet M, Lascaux H, Ouk-Martin C, Gachard N, Zimber-Strobl U, Feuillard J, Faumont N. c-Myc Dysregulation is a co-transforming event for nuclear factor-KB activated B cells. Haematologica. 2017 May;102(5):883-94. .

  203. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987 Dec 24;51(6):1079-90. .

  204. Hoesel B, Schmid JA. The complexity of NF-KB signaling in inflammation and cancer. Mol Cancer. 2013 Aug 2;12:86. .

  205. Sassone-Corsi P, Wildeman A, Chambon P. A trans-acting factor is responsible for the simian virus 40 enhancer activity in vitro. Nature. 1985 Feb 7-13;313(6002):458-63. .

  206. Cherrington JM, Mocarski ES. Human cytomegalovirus ie1 transactivates the a promoter-enhancer via an 18-base-pair repeat element. J Virol. 1989 Mar;63(3):1435-40. .

  207. Rong BL, Libermann TA, Kogawa K, Ghosh S, Cao LX, Pavan-Langston D, Dunkel EC. HSV-1-Inducible proteins bind to NF-KB-like sites in the HSV-1 genome. Virology. 1992 Aug;189(2):750-6. .

  208. Santoro MG, Rossi A, Amici C. NF-KB and Virus infection: who controls whom? EMBO J. 2003 Jun 2;22(11): 2552-60. .

  209. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-KB pathway. J Clin Invest. 2001 Jan;107(2):143-51. .

  210. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev. 2001 Mar;65(1):131-50. .

  211. Conant K, Ma M, Nath A, Major EO. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-KB binding and protein kinase C activity in primary human astrocytes. J Virol. 1996 Mar;70(3):1384-9. .

  212. Bonizzi G, Karin M. The two NF-KB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004 Jun;25(6):280-8. .

  213. Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC. Targeting IKB kinases for cancer therapy. Semin Cancer Biol. 2019 Jun;56:12-24. .

  214. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-KB signaling pathways. Nat Immunol. 2011 Jul 19;12(8):695-708. .

  215. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. .

  216. Perkins ND. The diverse and complex roles of NF-KB subunits in cancer. Nat Rev Cancer. 2012 Jan 19;12(2):121-32. .

  217. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. Stat3 regulates genes common to both wound healing and cancer. Oncogene. 2005 May 12;24(21):3397-408. .

  218. McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto G, Cervello M, Libra M, Nicoletti F, Scalisi A, Torino F, Fenga C, Neri LM, Marmiroli S, Cocco L, Martelli AM. Effects of mutations in Wnt/P-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta. 2016 Dec;1863(12):2942-76. .

  219. Xia Y, Shen S, Verma IM. NF-KB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823-30. .

  220. Perkins ND. NF-KB: tumor promoter or suppressor? Trends Cell Biol. 2004;14(2):64-9. .

  221. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 2005 Mar 23;24(6):1157-69. .

  222. Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-KB. Cell Death Differ. 2006 May; 13(5):759-72. .

  223. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-KB in p53-mediated programmed cell death. Nature. 2000 Apr 20;404(6780):892-7. .

  224. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC. p53 induces NF-KB activation by an IKB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem. 2004 Jun 18;279(25):26115-25. .

  225. Pires BRB, Silva RCMC, Ferreira GM, Abdelhay E. NF-KB: two sides of the same coin. Genes (Basel). 2018;9(1):E24. .

  226. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, White MR. Oscillations in NF-KB signaling control the dynamics of gene expression. Science. 2004;306(5696):704-8. .

  227. Figuera-Losada M, Rojas C, Slusher BS. Inhibition of microglia activation as a phenotypic assay in early drug discovery. J Biomol Screen. 2014 Jan;19(1):17-31. .

  228. Karunaweera N, Raju R, Gyengesi E, Munch G. Plant polyphenols as inhibitors of NF-KB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer's disease? Front Mol Neurosci. 2015 Jun 16;8:24. .

  229. Padmavathi G, Bordoloi D, Banik K, Monisha J, Singh AK, Kunnumakkara AB. Mechanism of chemoresistance in bone cancer and different chemosensitization approaches. In: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 81-106. .

  230. Pai S, Thomas R. Immune deficiency or hyperactivity-Nf-Kb illuminates autoimmunity. J Autoimmun. 2008 Nov;31(3):245-51. .

  231. Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP. The interaction of nuclear factor-KB and cytokines is associated with schizophrenia. Biol Psychiatry. 2009;65(6):481-8. .

  232. Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677-87. .

  233. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor KB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801-11. .

  234. Yokoo T, Kitamura M. Dual regulation of IL-1P-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-KB and AP-1. Am J Physiol. 1996;270(1 Pt 2):F123-30. .

  235. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-KB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998;28(4): 197-208. .

  236. Shih RH, Wang CY, Yang CM. NF-KB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci. 2015;8:77. .

  237. Prasad S, Ravindran J, Aggarwal BB. NF-KB and cancer: how intimate is this relationship? Mol Cell Biochem. 2010;336(1-2):25-37. .

  238. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and me-tastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29(3):405-34. .

  239. Ben-Neriah Y, Karin M. inflammation meets cancer, with NF-KB as the matchmaker. Nat Immunol. 2011; 12(8):715-23. .

  240. Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K. NF-KB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012;287(30):25530-40. .

  241. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Ag-garwal BB. NF-KB addiction and its role in cancer: one size does not fit all. Oncogene. 2011 Apr 7;30(14):1615-30. .

  242. Zhe J, Lizhi H, Aviv R, Kevin S. inflammatory regulatory network mediated by the joint action of NF-KB, STAT3, and AP-1 factors is involved in many human cancers. PNAS. 2019 May 7;116(19):9453-62. .

  243. Bordoloi D, Banik K, Khwairakpam AD, Sharma A, Sailo BL, Monisha J. Different approaches to overcome chemo-resistance in esophageal cancer. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 241-66. .

  244. Monisha J, Jaiswal A, Banik K, Harsha C, Singh AK, Bordoloi D, Kunnumakkara AB. Cancer cell chemoresistance: a prime obstacle in cancer therapy. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 15-50. .

  245. Roy NK, Sharma A, Singh AK, Bordoloi D, Sailo BL, Monisha J, Kunnumakkara AB. Bladder cancer: chemore-sistance and chemosensitization. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 51-80. .

  246. Khwairakpam AD, Monisha J, Banik K, Harsha C, Sharma A, Bordoloi D, Kunnumakkara AB. Chemoresistance in brain cancer and different chemosensitization approaches. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 107-28. .

  247. Banik K, Sailo BL, Thakur KK, Jaiswal A, Monisha J, Bordoloi D, Kunnumakkara AB. Potential of different chemosensitizers to overcome chemoresistance in cervical cancer. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 163-80. .

  248. Singh AK, Monisha J, Banik K, Harsha C, Khwairakpam AD, Bordoloi D, Kunnumakkara AB. Cancer cell chemo-resistance and chemosensitization in endometrial cancer. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 227-40. .

  249. Harsha C, Bordoloi D, Prakash J, Manteghi N, Padmavathi G, Monisha J, Kunnumakkara AB. Different chemosensitization approaches in gastric cancer. in: Kunnumakkara AB, editor. Cancer cell chemoresistance and chemosensitization. Hackensack, NJ: World Scientific; 2018. pp. 267-320. .

  250. Shabnam B, Padmavathi G, Banik K, Girisa S, Monisha J, Sethi G, Fan L, Wang L, Mao X, Kunnumakkara AB. Sorcin, a potential molecular target for cancer therapy. Transl Oncol. 2018 Dec;11(6):1379-89. .

  251. Bordoloi D, Roy NK, Monisha J, Padmavathi G, Kunnumakkara AB. Multi-targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far. Recent Pat Anticancer Drug Discov. 2016;11(1):67-97. .

  252. Fraser CC. Exploring the positive and negative conse-quences of NF-KB inhibition for the treatment of human disease. Cell Cycle. 2006;5(11):1160-3. .

  253. Jia H, Liu J, Han B. Reviews of interleukin-37: functions, receptors, and roles in diseases. Biomed Res int. 2018 Apr 1;2018:3058640. .

  254. Rudloff I, Cho SX, Lao JC, Ngo D, McKenzie M, Nold-Petry CA, Nold MF. Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells. J Leukoc Biol. 2017 Apr;101(4):901-11. .

  255. Sheikhpour E, Noorbakhsh P, Foroughi E, Farahnak S, Nasiri R, Neamatzadeh H. A survey on the role of inter-leukin-10 in breast cancer: a narrative. Rep Biochem Mol Biol. 2018 Oct;7(1):30-7. .

  256. Tang M, Dang R, Liu S, Zhang M, Zheng Y, Yang R, Yin T. fl-3 fatty acids supplementary in gestation alleviates neuro inflammation and modulates neurochemistry in rats. Lipids Health Dis. 2018 Nov 3;17(1):247. .

  257. Wang HW, Yang W, Lu JY, Li F, Sun JZ, Zhang W, Guo NN, Gao L, Kang JR. N-Acetylcysteine administration is associated with reduced activation of NF-KB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model. J Clin Immunol. 2013 Apr;33(3):649-60. .

  258. Harsha C, Banik K, Bordoloi D, Kunnumakkara AB. Antiulcer properties of fruits and vegetables: a mechanism based perspective. Food Chem Toxicol. 2017 Oct;108(Pt A):104-19. .

  259. Seo EJ, Fischer N, Efferth T. Phytochemicals as inhibitors of NF-KB for treatment of Alzheimer's disease. Pharmacol Res. 2018 Mar;129:262-73. .

  260. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195-218. .

  261. Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys. 2014 Oct 1;559:91-9. .

  262. Guruvayoorappan C, Sakthivel KM, Padmavathi G, Bakliwal V, Monisha J, Kunnumakkara AB. Cancer pre-ventive and therapeutic roles of fruits and vegetables: an overview. In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 1-52. .

  263. Jagadeeshan S, Kunnumakkara AB, Nair AS, Anticancer activities of fruits and vegetables against gynecological cancers. In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 131-59. .

  264. Mathew AJ, Padmavathi G, Kunnumakkara AB, Atulya M. Cancer chemopreventive and therapeutic properties of fruits and vegetables against head and neck malignancies. In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 161-83. .

  265. Sakthivel KM, Monisha J, Kunnumakkara AB, Guruvayo-orappan C. Cancer preventive and therapeutic properties of fruits and vegetables against lung cancer. In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 221-50. .

  266. Pandey MK, Kunnumakkara AB, Amin SG. Prostate cancer: how helpful are natural agents for prevention? In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 251-75. .

  267. Monisha J, Padmavathi G, Bakliwal V, Katre N, Padikkala J, Kunnumakkara AB. Cancer preventive and therapeutic properties of fruits and vegetables against commonly occurring cancers in humans. In: Kunnumakkara AB, editor. Anticancer properties of fruits and vegetables: a scientific review. Hackensack, NJ: World Scientific; 2015. pp. 337-68. .

  268. Tanabe K, Matsushima-Nishiwaki R, Yamaguchi S, Iida H, Dohi S, Kozawa O. Mechanisms of tumor necrosis factor-a-induced interleukin-6 synthesis in glioma cells. J Neuroinflammation. 2010;7:16. .

  269. Yamaguchi M, Arbiser JL, Weitzmann MN. Honokiol stimulates osteoblastogenesis by suppressing NF-KB activation. Int J Mol Med. 2011;28(6):1049-53. .

  270. Butturini E, Di Paola R, Suzuki H, Paterniti I, Ahmad A, Mariotto S, Cuzzocrea S. Costunolide and dehydrocostus-lactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisy in mice. Eur J Pharmacol. 2014;730:107-15. .

  271. Whipple RA, Vitolo MI, Boggs AE, Charpentier MS, Thompson K, Martin SS. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-KB inhibition. Breast Cancer Res. 2013;15(5):R83. .

  272. Natarajan K, Singh S, Burke Jr TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-KB. Proc Natl Acad Sci. 1996;93(17):9090-5. .

  273. Singh S, Aggarwal BB. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-KB. J Biol Chem. 1995;270(18):10631-9. .

  274. Karki R, Ho OM, Kim DW. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-KB activation in vascular smooth muscle cells. Biochim Biophys Acta. 2013;1830(3):2619-28. .

  275. Wang C, Li S, Wang MW. Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/ Akt/caspase and Fas-L/NF-KB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro. 2010;24(3):898-904. .

  276. Zang L, He H, Ye Y, Liu W, Fan S, Tashiro S, Onodera S, Ikejima T. Nitric oxide augments oridonin-induced efferocytosis by human histocytic lymphoma U937 cells via autophagy and the NF-KB-COX-2-IL-1P pathway. Free Radic Res. 2012;46(10):1207-19. .

  277. Wei W, Huang H, Zhao S, Liu W, Liu CX, Chen L, Li JM, Wu YL, Yan H. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-KB inhibition and Bcr/Abl protein deletion. Apoptosis. 2013;18(9):1060-70. .

  278. Jia QQ, Wang JC, Long J, Zhao Y, Chen SJ, Zhai JD, Wei LB, Zhang Q, Chen Y, Long HB. Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-KB activation and MCP-1 and TGF-P1 expression in rat mesangial cells. Molecules. 2013;18(10):13061-77. .

  279. Koh DJ, Ahn HS, Chung HS, Lee H, Kim Y, Lee JY, Kim DG, Hong M, Shin M, Bae H. Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-KB inactivation. J Ethnopharmacol. 2011;136(3):399-405. .

  280. Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M, Liu JG, Pei XH, Wang LJ, Lin ZX, Gupta K, Mackman N, Slungaard A, Key NS, Geng JG. NF-KB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem. 2009;284(7):4473-83. .

  281. Lee SH, Bae EA, Park EK, Shin YW, Baek NI, Han EJ, Chung HG, Kim DH. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps in IgE-induced hypersensitivity. Int Immunopharmacol. 2007;7(13):1678-84. .

  282. Sen CK, Roy S, Packer L. Involvement of intracellular Ca2+ in oxidant-induced NF-KB activation. FEBS Lett. 1996;385(1-2):58-62. .

  283. Park MH, Hong JT. Roles of NF-KB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016;5(2):E15. .

  284. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993;12(8):3095-104. .

  285. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-KB and activated protein-1. J Biol Chem. 1998;273(21):13245-54. .

  286. Kopp E, Ghosh S. Inhibition of NF-KB by sodium salicylate and aspirin. Science. 1994;265(5174):956-9. .

  287. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonste-roidal anti-inflammatory agents differ in their ability to suppress NF-KB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004;23(57):9247-58. .

  288. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-KB activation. Science. 1996;274(5291):1383-5. .

  289. Palayoor ST, Bump EA, Calderwood SK, Bartol S, Coleman CN. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin Cancer Res. 1998;4(3):763-71. .

  290. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IKB kinase-p. Nature. 1998;396(6706):77-80. .

  291. Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR. Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem. 2006;281(39):29228-35. .

  292. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates of targeted disruption of Ikkp. Science. 2001;293(5535):1673-7. .

  293. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62(4):499-506. .

  294. He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T, Sieghart W, Peck-Radosavljevic M, Leffert HL, Karin M. Hepatocyte IKKp/NF-KB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 2010;17(3):286-97. .

  295. Liu JL, Pan YY, Chen O, Luan Y, Xue X, Zhao JJ, Liu L, Jia HY. Curcumin inhibits MCF-7 cells by modulating the NF-KB signaling pathway. Oncol Lett. 2017 Nov; 14(5):5581-84. .

  296. Marquardt JU, Gomez-Quiroz L, Arreguin Camacho LO, Pinna F, Lee YH, Kitade M, Dommguez MP, Castven D, Breuhahn K, Conner EA, Galle PR, Andersen JB, Factor VM, Thorgeirsson SS. Curcumin effectively inhibits on-cogenic NF-KB signaling and restrains stemness features in liver cancer. J Hepatol. 2015;63(3):661-9. .

  297. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "curecumin": from kitchen to clinic. Biochem Pharmacol. 2008 Feb 15;75(4):787-809. .

  298. Aggarwal BB, Deb L, Prasad S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules. 2014 Dec 24;20(1):185-205. .

  299. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008 Aug 18;267(1):133-64. .

  300. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer. 2009 Nov 1;125(9):2187-97. .

  301. Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. y-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory micro-environment. Cancer Res. 2010 Nov 1;70(21):8695-705. .

  302. Brennan P, O'Neill LA. Inhibition of nuclear factor KB by direct modification in whole cells-mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol. 1998;55(7):965-73. .

  303. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-KB activation through inhibition of IKBa kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis. 2003;24(7):1269-79. .

  304. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-KB and IKBa kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003;101(3):1053-62. .

  305. Leclercq IA, Farrell GC, Sempoux C, dela Pena A, Horsmans Y. Curcumin inhibits NF-KB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004 Dec;41(6):926-34. .

  306. Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-KB and NF-KB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclasto-genesis. Mol Nutr Food Res. 2012 Mar;56(3):454-65. .

  307. Van't Land B, Blijlevens NM, Marteijn J, Timal S, Donnelly JP, De Witte TJ, M'Rabet L. Role of curcumin and the inhibition of NF-KB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia. 2004 Feb;18(2):276-84. .

  308. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydro-curcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr. 2001 Aug;131(8):2090-5. .

  309. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-KB-dependent genes. Am J Physiol Gastrointest Liver Physiol. 2003 Feb;284(2):G321-7. .

  310. Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol. 2000 Apr;52(4):437-40. .

  311. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and anti-apoptotic and metastatic gene products through suppression of IKBa kinase and Akt activation. Mol Pharmacol. 2006 Jan;69(1):195-206. .

  312. Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH, Pace TW. Inhibition of the NF-KB signaling pathway by the curcumin analog, 3,5-bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol. 2012;12(2):368-77. .

  313. Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, Motilva V, Alarcon de la Lastra C. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007;7(3):333-42. .

  314. Chen YR, Tan TH. Inhibition of the c-Jun N-terminal kinase (JNK) signalling pathway by curcumin. Oncogene. 1998;17(2):173-8. .

  315. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit nuclear factor-KB-mediated cytokine expression in adipocytes. Nutr Metab (Lond). 2008 Jun 12;5:17. .

  316. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75. .

  317. Buhrmann C, Popper B, Aggarwal BB, Shakibaei M. Resveratrol downregulates inflammatory pathway activated by lymphotoxin a (TNF-P) in articular chondrocytes: comparison with TNF-a. PLoS One. 2017 Nov 2;12(11):e0186993. .

  318. Ghasemi F, Shafiee M, Banikazemi Z, Pourhanifeh MH, Khanbabaei H, Shamshirian A, Amiri Moghadam S, Aref-Nezhad R, Sahebkar A, Avan A, Mirzaei H. Curcumin inhibits NF-KB and Wnt/p-catenin pathways in cervical cancer cells. Pathol Res Pract. 2019 Oct;215(10):152556. .

  319. Li N, Liu TH, Yu JZ, Li CX, Liu Y, Wu YY, Yang ZS, Yuan JL. Curcumin and curcumol inhibit NF-KB and TGF-P1/ Smads signaling pathways in CSE-treated RAW246.7 cells. Evid Based Complement Alternat Med. 2019 Mar17;2019:3035125. .

  320. Kalaitzidis D, Gilmore TD. Transcription factor crosstalk: the estrogen receptor and NF-KB. Trends Endocrinol Metab. 2005;16(2):46-52. .

  321. De Bosscher K, Vanden Berghe W, Haegeman G. Crosstalk between nuclear receptors and nuclear factor KB. Oncogene. 2006;25(51):6868-86. .

  322. Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-KB inhibition and gene expression signature. Mol Pharmacol. 2006;69(5):1615-23. .

  323. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA. Calcineurin acts in synergy with PMA to inactivate IKB/MAD3, an inhibitor of NF-KB. EMBO J. 1994;13(4):861-70. .

  324. McCaffrey PG, Kim PK, Valge-Archer VE, Sen R, Rao A. Cyclosporin A sensitivity of the NF-KB site of the IL2R a promoter in untransformed murine T cells. Nucleic Acids Res. 1994;22(11):2134-42. .

  325. Sen J, Venkataraman L, Shinkai Y, Pierce JW, Alt FW, Burakoff SJ, Sen R. Expression and induction of nuclear factor-KB-related proteins in thymocytes. J Immunol. 1995;154(7):3213-21. .

  326. Hirano F, Kobayashi A, Makino I. Inhibition of TNF-a-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs. Int Immuno-pharmacol. 2003;3(2):225-32. .

  327. Wolf AM, Wolf D, Rumpold H, Ludwiczek S, Enrich B, Gastl G, Weiss G, Tilg H. The kinase inhibitor imatinib mesylate inhibits TNF-a production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc Natl Acad Sci. 2005;102(38):13622-7. .

  328. Jamdade VS, Mundhe NA, Kumar P, Tadla V, Lahkar M. Raloxifene inhibits NF-KB pathway and potentiates anti-tumour activity of cisplatin with simultaneous reduction in its nephrotoxicity. Pathol Oncol Res. 2016 Jan;22(1):145-53. .

  329. Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg. 2004;40(2):334-8. .

  330. Acarin L, Gonzalez B, Castellano B. Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-KB in the postnatal rat brain. Neurosci Lett. 2000; 288(1):41-4. .

  331. Ruan H, Pownall HJ, Lodish HF. Troglitazone antagonizes tumor necrosis factor-a-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-KB. J Biol Chem. 2003;278(30):28181-92. .

  332. Perrott KM, Wiley CD, Desprez PY, Campisi J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience. 2017 Apr;39(2):161-73. .

  333. He J, Lu X, Wei T, Dong Y, Cai Z, Tang L, Liu M. Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-KB and MAPK signaling pathways in LPS-induced RAW264.7 macrophages. Int J Mol Sci. 2018 Jul 12;19(7):2027. .

  334. Tanaka T, de Azevedo MB, Duran N, Alderete JB, Epifano F, Genovese S, Tanaka M, Tanaka T, Curini M. Colorectal cancer chemoprevention by 2 P-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid. Int J Cancer. 2010 Feb 15;126(4):830-40. .

  335. Dirsch VM, Gerbes AL, Vollmar AM. Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor KB. Mol Pharmacol. 1998 Mar;53(3):402-7. .

  336. Anandasadagopan SK, Sundaramoorthy C, Pandurangan AK, Nagarajan V, Srinivasan K, Ganapasam S. S-Allyl cysteine alleviates inflammation by modulating the expression of NF-KB during chromium (VI)-induced hepatotoxicity in rats. Hum Exp Toxicol. 2017 Nov;36(11):1186-1200. .

  337. Zhang M, Cui Z, Cui H, Wang Y, Zhong C. Astaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC expression via the NF-KB signaling pathway. BMC Neurosci. 2017 May 10;18(1):42. .

  338. Chen CH, De Graffenried LA. Anethole suppressed cell survival and induced apoptosis in human breast cancer cells independent of estrogen receptor status. Phytomedicine. 2012 Jun 15;19(8-9):763-7. .

  339. Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-P-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-KB and NF-KB-regulated gene expression. J Immunol. 2006 Mar 1;176(5):3127-40. .

  340. Suzuki YJ, Aggarwal BB, Packer L. Alphalipoic acid is a potent inhibitor of NF-KB activation in human T cells. Biochem Biophys Res Commun. 1992 Dec 30; 189(3):1709-15. .

  341. Zhang L, Chen Q, Wang H, Yang J, Sheng S. Andrographolide mitigates IL-1P-induced human nucleus pulposus cells degeneration through the TLR4/ MyD88/NF-KB signaling pathway. Mol Med Rep. 2018 Dec;18(6):5427-543. .

  342. Seong YA, Shin PG, Kim GD. Anacardic acid induces mito-chondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. Int J Oncol. 2013Mar;42(3):1045-51. .

  343. Lee YJ, Chung JG, Chien YT, Lin SS, Hsu FT. Suppression of ERK/NF-KB activation is associated with amentoflavone-inhibited osteosarcoma progression in vivo. Anticancer Res. 2019 Jul;39(7):3669-75. .

  344. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IKBa kinase, suppresses nuclear factor-KB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008 Jul 1;68(13):5370-9. .

  345. Sung B, Cho SG, Liu M, Aggarwal BB. Butein, a tet-rahydroxychalcone, suppresses cancer-induced osteo-clastogenesis through inhibition of receptor activator of nuclear factor-KB ligand signaling. Int J Cancer. 2011 Nov 1;129(9):2062-72. .

  346. Takada Y, Aggarwal BB. Betulinic acid suppresses carcinogen-induced NF-KB activation through inhibition of IKBa kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol. 2003 Sep 15;171(6):3278-86. .

  347. Han J, Ma D, Zhang M, Yang X, Tan D. Natural antioxidant betanin protects rats from paraquat-induced acute lung injury interstitial pneumonia. Biomed Res Int. 2015;2015:608174. .

  348. Wang F, Wang N, Gao Y, Zhou Z, Liu W, Pan C, Yin P, Yu X, Tang M. P-Carotene suppresses osteoclastogenesis and bone resorption by suppressing NF-KB signaling pathway. Life Sci. 2017 Apr 1;174:15-20. .

  349. Natarajan K, Singh S, Burke Jr TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-KB. Proc Natl Acad Sci. 1996 Aug 20;93(17):9090-5. .

  350. Janyou A, Wicha P, Jittiwat J, Suksamrarn A, Tocharus C, Tocharus J. Dihydrocapsaicin attenuates blood brain barrier and cerebral damage in focal cerebral ischemia/reper-fusion via oxidative stress and inflammatory. Sci Rep. 2017 Sep 5;7(1):10556. .

  351. Bak MJ, Hong SG, Lee JW, Jeong WS. Red ginseng marc oil inhibits iNOS and COX-2 via NFKB and p38 pathways in LPS-stimulated RAW 264.7 macrophages. Molecules. 2012 Nov 22;17(12):13769-86. .

  352. Park SY, Kim YH, Park G. Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-KB inhibition. Neurosci Lett. 2015 Nov 16;609:129-36. .

  353. Tyagi AK, Prasad S, Majeed M, Aggarwal BB. Calebin A, a novel component of turmeric, suppresses NF-KB regulated cell survival and inflammatory gene products leading to inhibition of cell growth and chemosensitization. Phytomedicine. 2017 Oct 15;34:171-81. .

  354. Manna SK, Bueso-Ramos C, Alvarado F, Aggarwal BB. Calagualine inhibits nuclear transcription factors-KB activated by various inflammatory and tumor promoting agents. Cancer Lett. 2003 Feb 20;190(2):171-82. .

  355. Kumar N, Gangappa D, Gupta G, Karnati R. Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFKB and induces apoptosis in retinoblastoma cells. BMC Complement Altern Med. 2014 Aug 29;14:319. .

  356. Shanmuganathan S, Angayarkanni N. Chebulagic acid, chebulinic acid, and gallic acid, the active principles of Triphala, inhibit TNFa induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFKB phosphorylation. Vascul Pharmacol. 2018 Sep;108:23-35. .

  357. Tan S, Xu J, Lai A, Cui R, Bai R, Li S, Liang W, Zhang G, Jiang S, Liu S, Zheng M, Wang W. Curculigoside exerts significant anti-arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF-KB signaling pathway. Mol Med Rep. 2019 Mar;19(3):2057-64. .

  358. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-KB-regulated gene products. Cancer Res. 2007 Apr 15;67(8):3853-61. .

  359. Tsai YC, Chang HW, Chang TT, Lee MS, Chu YT, Hung CH. Effects of all-trans retinoic acid on Th1- and Th2-related chemokines production in monocytes. Inflammation. 2008 Dec;31(6):428-33. .

  360. Gong X, Marisiddaiah R, Zaripheh S, Wiener D, Rubin LP. Mitochondrial P-carotene 9',10' oxygenase modulates prostate cancer growth via NF-KB inhibition: a lycopene-independent function. Mol Cancer Res. 2016 Oct;14(10):966-75 .

  361. Liu XR, Wang YY, Dan XG, Kumar A, Ye TZ, Yu YY, Yang LG. Anti-inflammatory potential of P-cryptoxanthin against LPS-induced inflammation in mouse Sertoli cells. Reprod Toxicol. 2016 Apr;60:148-55. .

  362. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL, Hsieh YS. Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett. 2006 Apr 28;235(2):248-59. .

  363. Nair AS, Shishodia S, Ahn KS, Kunnumakkara AB, Sethi G, Aggarwal BB. Deguelin, an Akt inhibitor, suppresses IKBa kinase activation leading to suppression of NF-KB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol. 2006 Oct 15;177(8):5612-22. .

  364. Im NK, Jang WJ, Jeong CH, Jeong GS. Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-KB activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells. J Med Food. 2014 Aug;17(8):855-61. .

  365. Saud SM, Li W, Gray Z, Matter MS, Colburn NH, Young MR, Kim YS. Diallyl disulfide (DADS), a constituent of garlic, inactivates NF-KB and prevents colitis-induced colorectal cancer by inhibiting GSK-3P. Cancer Prev Res (Phila). 2016 Jul;9(7):607-15. .

  366. Shishodia S, Aggarwal BB. Diosgenin inhibits osteo-clastogenesis, invasion, and proliferation through the downregulationofAkt,IKBkinaseactivationandNF-KB-regulated gene expression. Oncogene. 2006 Mar 9;25(10): 1463-73. .

  367. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor KB and induction of apoptosis. Oncogene. 2004 Apr 1;23(14):2507-22. .

  368. El-Shitany NA, El-Bastawissy EA, El-desoky K. Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor KB, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol. 2014Apr;19(2):290-9. .

  369. Liu Q, Wang Q, Li H. Embelin inhibits abdominal aortic aneurysm through decreasing IL-6-induced STAT3 and NF-KB inactivation. Mol Med Rep. 2018 Aug; 18(2):2365-72. .

  370. Kumar A, Dhawan S, Aggarwal BB. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-KB activation, IKB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene. 1998 Aug 20;17(7):913-8. .

  371. Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB. Escin, a pentacyclic triterpene, chemo-sensitizes human tumor cells through inhibition of nuclear factor-KB signaling pathway. Mol Pharmacol. 2010 May;77(5):818-27. .

  372. Murakami Y, Shoji M, Hanazawa S, Tanaka S, Fujisawa S. Preventive effect of biseugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor KB activation and inflammatory cytokine expression in macrophages. Biochem Pharmacol. 2003 Sep 15;66(6):1061-6. .

  373. Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine abolishes constitutive and inducible NF-KB activation by inhibiting IKBa kinase activation, thereby suppressing NF-KB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem. 2005 Apr 29;280(17):17203-12. .

  374. Lee S, Ro H, In HJ, Choi JH, Kim MO, Lee J, Hong ST, Lee SU. Fisetin inhibits TNF-a/NF-KB-induced IL-8 expression by targeting PKCS in human airway epithelial cells. Cytokine. 2018 Aug;108:247-54. .

  375. Cao YJ, Zhang YM, Qi JP, Liu R, Zhang H, He LC. Ferulic acid inhibits H2O2-induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NADPH oxidase and NF-KB pathway. Int Immuno-pharmacol. 2015 Oct;28(2):1018-25. .

  376. Huang L, Hou L, Xue H, Wang C. Gallic acid inhibits inflammatory response of RAW264.7 macrophages by blocking the activation of TLR4/NF-KB induced by LPS. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Dec;32(12):1610-4. .

  377. Zhao K, Zhang S, Song X, Yao Y, Zhou Y, You Q, Guo Q, Lu N. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFP1-induced epithelial-to-mesenchymal transition. Oncotarget. 2017 Apr 18;8(16): 27120-36. .

  378. Wang A, Wei J, Lu C, Chen H, Zhong X, Lu Y, Li L, Huang H, Dai Z, Han L. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-KB-dependent mechanism in keratinocytes. Int Immunopharmacol. 2019 Apr;69:270-8. .

  379. Liang N, Sang Y, Liu W, Yu W, Wang X. Antiinflammatory effects of gingerol on lipopolysaccharide-stimulated RAW 264.7 cells by inhibiting NF-KB signaling pathway. Inflammation. 2018 Jun;41(3):835-45. .

  380. Yuan Z, Jiang H, Zhu X, Liu X, Li J. Ginsenoside Rg3 promotes cytotoxicity of paclitaxel through inhibiting NF-KB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomed Pharmacother. 2017 May;89:227-32. .

  381. Kim JH, Park DK, Lee CH, Yoon DY. A new isoflavone glycitein 7-O-P-D-glucoside 4''-O-methylate, isolated from Cordyceps militaris grown on germinated soybeans extract, inhibits EGF-induced mucus hypersecretion in the human lung mucoepidermoid cells. Phytother Res. 2012 Dec;26(12):1807-12. .

  382. ichikawa H, Aggarwal BB. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-KB ligand and by tumor cells by suppressing nuclear factor-KB activation. Clin Cancer Res. 2006 Jan 15;12(2):662-8. Erratum in Clin Cancer Res. 2018 Sep 1;24(17):4347. .

  383. Kunnumakkara AB, Nair AS, Ahn KS, Pandey MK, Yi Z, Liu M, Aggarwal BB. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor P-activated kinase-1-mediated NF-KB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood. 2007 Jun 15;109(12):5112-21. .

  384. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-KB activation pathway. Mol Cancer Res. 2006 Sep;4(9):621-33. .

  385. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-KB and IKBa kinase activation, causing inhibition of expression of NF-KB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood. 2005 Jul 15;106(2):641-9. .

  386. Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB. indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-KB signaling pathway. J Biol Chem. 2006 Aug 18;281(33):23425-35. .

  387. Chang J, Zhang Y, Li Y, Lu K, Shen Y, Guo Y, Qi Q, Wang M, Zhang S. NrF2/ARE and NF-KB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cells. Future Oncol. 2018 Apr; 14(8):719-26. .

  388. Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, Jin Y, Xu X, Li-ang G. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-KB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. 2019 Jun;59:152774. .

  389. Khan I, Chowdhury MMR, Song SH, Mesalam A, Zhang S, Khan Khalil AA, Jung EH, Kim JB, Jafri L, Mirza B, Kong IK. Lupeol supplementation improves the developmental competence of bovine embryos in vitro. Theriogenology. 2018 Feb;107:203-10. .

  390. Jeong Y, Lim JW, Kim H. Lycopene inhibits reactive oxygen species-mediated NF-KB signaling and induces apoptosis in pancreatic cancer cells. Nutrients. 2019 Apr 1;11(4):E762. .

  391. Majumdar S, Aggarwal BB. Methotrexate suppresses NF-KB activation through inhibition of iKBa phos-phorylation and degradation. J Immunol. 2001 Sep 1;167(5):2911-20. .

  392. Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB. Oleandrin suppresses activation of nuclear transcription factor-KB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res. 2000 Jul 15;60(14):3838-47. .

  393. Arora R, Bharti V, Gaur P, Aggarwal S, Mittal M, Das SN. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-KB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells. Arch Oral Biol. 2017 Aug;80:1-9. .

  394. Hwang JM, Yu JY, Jang YO, Kim BT, Hwang KJ, Jeon YM, Lee JC. A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture. int immunopharmacol. 2010 Apr;10(4):526-32. .

  395. Li L, Jin X, Zhang H, Yin J. Protective effect of picroliv against lipopolysaccharide-induced cognitive dysfunction and neuroinflammation by attenuating TLR4/NFKB pathway. Folia Neuropathol. 2018;56(4):337-45. .

  396. Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. Piceatannol inhibits TNF-induced NF-KB activation and NF-KB-mediated gene expression through suppression of iKBa kinase and p65 phosphorylation. J Immunol. 2002 Dec 1;169(11):6490-7. .

  397. Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-KB and Bcl-2. J Cell Biochem. 2008 Dec 15;105(6):1461-71. .

  398. Manu KA, Kuttan G. Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-KB signaling. Asian Pac J Cancer Prev. 2009;10(6):1031-7. .

  399. Cheng X, Yao X, Xu S, Pan J, Yu H, Bao J, Guan H, Lu R, Zhang L. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-KB signaling pathway. Biomed Pharmacother. 2018 Jul;103:490-8. .

  400. Sung NY, Yang MS, Song DS, Byun EB, Kim JK, Park JH, Song BS, Lee JW, Park SH, Park HJ, Byun MW, Byun EH, Kim JH. The procyanidin trimer C1 induces macrophage activation via NF-KB and MAPK pathways, leading to Th1 polarization in murine splenocytes. Eur J Pharmacol. 2013 Aug 15;714(1-3):218-28. .

  401. Murakami A, Song M, Ohigashi H. Phenethyl isothiocyanate suppresses receptor activator of NF-KB ligand (RANKL)-induced osteoclastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macro-phages. Biofactors. 2007;30(1):1-11. .

  402. Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-KB, degradation of iKBa, nuclear translocation of p65, and subsequent gene expression. Arch Biochem Biophys. 1998 Apr 1;352(1):59-70. .

  403. Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2010 Jul 15;127(2):257-68. .

  404. Cao W, Hu C, Wu L, Xu L, Jiang W. Rosmarinic acid inhibits inflammation and angiogenesis of hepatocellular carcinoma by suppression of NF-KB signaling in H22 tumorbearing mice. J Pharmacol Sci. 2016 Oct; 132(2): 131-7. .

  405. Chaturvedi MM, Kumar A, Darnay BG, Chainy GB, Agarwal S, Aggarwal BB. Sanguinarine (pseudochel-erythrine) is a potent inhibitor of NF-KB activation, IKBa phosphorylation, and degradation. J Biol Chem. 1997 Nov 28;272(48):30129-34. .

  406. Kim KA, Lee IA, Gu W, Hyam SR, Kim DH. P-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 in the NF-KB pathway. Mol Nutr Food Res. 2014 May;58(5):963-72. .

  407. Bannwart CF, Nakaira-Takahagi E, Golim MA, de Medeiros LT, Romao M, Weel IC, Perajoli MT. Downregulation of nuclear factor-KB (NF-KB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis. Life Sci. 2010 Jun 5;86(23-24):880-6. .

  408. Gabay O, Sanchez C, Salvat C, Chevy F, Breton M, Nourissat G, Wolf C, Jacques C, Berenbaum F. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. Osteoarthritis Cartilage. 2010 Jan;18(1):106-16. .

  409. Burnett JP, Lim G, Li Y, Shah RB, Lim R, Paholak HJ, McDermott SP, Sun L, Tsume Y, Bai S, Wicha MS, Sun D, Zhang T. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Lett. 2017 May 28;394:52-64. .

  410. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. Silymarin suppresses TNF-induced activation of NF-KB, c-Jun N-terminal kinase, and apoptosis. J Immunol. 1999 Dec 15;163(12):6800-9. .

  411. Sun X, Li L, Ma HG, Sun P, Wang QL, Zhang TT, Shen YM, Zhu WM, Li X. Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-KB p65 pathway. Acta Pharmacol Sin. 2017 Apr;38(4):524-38. .

  412. Sethi G, Ahn KS, Aggarwal BB. Targeting nuclear factor-KB activation pathway by thymoquinone: role in sup-pression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008 Jun;6(6):1059-70. .

  413. Reuter S, Gupta SC, Phromnoi K, Aggarwal BB. Thio-colchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug. Br J Pharmacol. 2012 Apr;165(7):2127-39. .

  414. Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. y-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules. Br J Cancer. 2016 Sep 27;115(7):814-24. .

  415. Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, DeorukhkarA, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, Guha S, Aggarwal BB. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 2012 Sep 15;18(18):4942-53. .

  416. Pratheeshkumar P, Kuttan G. Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-KB-mediated bcl-2 activation. Drug Chem Toxicol. 2011 Jul;34(3):261-70. .

  417. Manna SK, Aggarwal BB. Wortmannin inhibits activation of nuclear transcription factors NF-KB and activated protein-1 induced by lipopolysaccharide and phorbol ester. FEBS Lett. 2000 May 4;473(1):113-8. .

  418. Wang Y, Chen Y, Wang J, Chen J, Aggarwal BB, Pang X, Liu M. Xanthohumol, a prenylated chalcone derived from hops, suppresses cancer cell invasion through inhibiting the expression of CXCR4 chemokine receptor. Curr Mol Med. 2012 Feb;12(2):153-62. .

  419. Tsuboi K, Matsuo Y, Shamoto T, Shibata T, Koide S, Morimoto M, Guha S, Sung B, Aggarwal BB, Takahashi H, Takeyama H. Zerumbone inhibits tumor angiogenesis via NF-KB in gastric cancer. Oncol Rep. 2014 Jan;31(1):57-64. .

  420. Xiao J, Wang J, Xing F, Han T, Jiao R, Liong EC, Fung ML, So KF, Tipoe GL. Zeaxanthin dipalmitate therapeuti-cally improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway. PLoS One. 2014 Apr 16;9(4):e95214. .

  421. Roozbehkia M, Mahmoudi M, Aletaha S, Rezaei N, Fattahi MJ, Jafarnezhad-Ansariha F, Barati A, Mirshafiey A. The potent suppressive effect of P-D-mannuronic acid (M2000) on molecular expression of the TLR/NF-KB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 2017 Nov;52:191-96. .

  422. Fuller KNZ, Summers CM, Valentine RJ. Effect of a single bout of aerobic exercise on high-fat meal-induced in-flammation. Metabolism. 2017;71:144-52. .

  423. Kwon HH, Moon KR, Park SY, Yoon JY, Suh DH, Lee JB. Daylight photodynamic therapy with 1.5 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: a double-blind randomized controlled trial. J Dermatol. 2016;43(5):515-21. .

  424. Yong Y, Zhenhuan M, Guokai Y, Jia W, Guojian L, Lingjuan D, Ping L. Alginate oligosaccharide indirectly affects toll-like receptor signaling via the inhibition of microRNA-29b in aneurysm patients after endovascular aortic repair. Drug Des Devel Ther. 2017 Sep 1;2017(11):2565-79. .

  425. Li M, Yu L, She T, Gan Y, Liu F, Hu Z, Chen Y, Li S, Xia H. Astragaloside IV attenuates Toll-like receptor 4 expression via NF-KB pathway under high glucose condition in mesenchymal stem cells. Eur J Pharmacol. 2012 Dec 5;696(1-3):203-9. .

  426. Block RC, Abdolahi A, Smith B, Meednu N, Thevenet-Morrison K, Cai X, Cui H, Mousa S, Brenna JT, Georas S. Effects of low-dose aspirin and fish oil on platelet function and NF-KB in adults with diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2013 Jul;89(1):9-18. .

  427. Koenig R, Dickman JR, Kang C, Zhang T, Chu YF, Ji LL. Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women. Nutr J. 2014 Mar 19;13:21. .

  428. Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreef M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ. A phase I first-inhuman trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res. 2012;18(12):3396-406. .

  429. Sulzberger M, Worthmann AC, Holtzmann U, Buck B, Jung KA, Schoelermann AM, Rippke F, Stab F, Wenck H, Neufang G, Gronniger E. Effective treatment for sensitive skin: 4-t-Butylcyclohexanol and licochalcone A. J Eur Acad Dermatol Venereol. 2016 Jan 25;30(1):9-17. .

  430. Sunakawa Y, Stintzing S, Cao S, Heinemann V, Cremolini C, Falcone A, Yang D, Zhang W, Ning Y, Stremitzer S, Matsusaka S, Yamauchi S, Parekh A, Okazaki S, Berger MD, Graver S, Mendez A, Scherer SJ, Loupakis F, Lenz HJ. Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials. Ann Oncol. 2015 Dec;26(12):2450-6. .

  431. Daher M, Hidalgo Lopez JE, Randhawa JK, Jabbar KJ, Wei Y, Pemmaraju N, Borthakur G, Kadia T, Konopleva M, Kantarjian HM, Hearn K, Estrov Z, Reyes S, Bueso-Ramos CE, Garcia-Manero G. An exploratory clinical trial of bortezomib in patients with lower risk myelo-dysplastic syndromes. Am J Hematol. 2017 Jul;92(7): 674-82. .

  432. Howard DS, Liesveld J, Phillips GL, 2nd, Hayslip J, Weiss H, Jordan CT, Guzman ML. A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia. Leuk Res. 2013;37(11):1502-8. .

  433. Yan P, Qin O. Therapeutic effect and mechanisms study of bawei xilei powder on ulcerative colitis patients. Zhong-guo Zhong Xi Yi Jie He Za Zhi. 2014;34(1):27-30. .

  434. Darabi Z, Darand M, Yari Z, Hedayati M, Faghihi A, Agah S, Hekmatdoost A. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial. BMC Res Notes. 2019 Feb 15;12(1):89. .

  435. Gelmini F, Beretta G, Anselmi C, Centini M, Magni P, Ruscica M, Cavalchini A, Maffei Facino R. GC-MS Profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int J Pharm. 2013 Jan 20;440(2):170-8. .

  436. Sun T, Dong W, Jiang G, Yang J, Liu J, Zhao L, Ma P. Cordyceps militaris improves chronic kidney disease by affecting TLR4/NF-KB redox signaling pathway. Oxid Med Cell Longev. 2019 Mar 31;2019:7850863. .

  437. Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol. 2013;71(6):1521-30. .

  438. Kuriakose MA, Ramdas K, Dey B, Iyer S, Rajan G, Elango KK, Suresh A, Ravindran D, Kumar RR, Ramachandran S, Kumar NA, Thomas G, Somanathan T, Ravindran HK, Ranganathan K, Katakam SB, Parashuram S, Jayaprakash V, Pillai MR. A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia. Cancer Prev Res (Phila). 2016 Aug;9(8):683-91. .

  439. Al-Homsi AS, Lai Z, Roy TS, Al-Malki MM, Kouttab N, Junghans RP. Post-transplant cyclophosphamide and bortezomib inhibit dendritic cell maturation and function and alter their IKB and NFKB. Transpl Immunol. 2014;30(1):40-5. .

  440. Zhang Y, Li JL, Fu Q, Wang XD, Liu LS, Wang CX, Xie W, Chen ZJ, Shu WY, Huang M. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclo-sporine trough concentrations in Chinese renal transplant recipients. Acta Pharmacol Sin. 2013 Apr;34(4):555-60. .

  441. Kater AP, Spiering M, Liu RD, Doreen Te Raa G, Slinger E, Tonino SH, Beckers MM, Daenen S, Doorduijn JK, Lankheet NA, Luijks DM, Eldering E, van Oers MH. Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study. Leuk Res. 2014 Jan;38(1):34-41. .

  442. Kim JY, Kwon HY, Kim KS, Kim MK, Kwon O. Post-prandial glucose and NF-KB responses are regulated differently by monounsaturated fatty acid and dietary fiber in impaired fasting glucose subjects. J Med Food. 2013;16(12):1168-71. .

  443. Dong W, Chen MH, Yang YH, Zhang X, Huang MJ, Yang XJ, Wang HZ. The effect of dexmedetomidine on expressions of inflammatory factors in patients with radical resection of gastric cancer. Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3510-5. .

  444. Ueki M, Kawasaki T, Habe K, Hamada K, Kawasaki C, Sata T. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia. 2014;69(7):693-700. .

  445. Morikawa M, Nakano S, Mitsui N, Murasawa H, Masuki S, Nose H. Effects of dried tofu supplementation during interval walking training on the methylation of the NFKB2 gene in the whole blood of older women. J Physiol Sci. 2018;68(6):749-57. .

  446. Donovan JM, Zimmer M, Offman E, Grant T, Jirousek M. A novel NF-KB inhibitor, edasalonexent (CAT-1004), in development as a disease-modifying treatment for patients with Duchenne muscular dystrophy: phase 1 safety, pharmacokinetics, and pharmacodynamics in adult subjects. J Clin Pharmacol. 2017;57(5):627-39. .

  447. Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol. 2013;133(2):429-40. .

  448. Williams EJ, Baines KJ, Berthon BS, Wood LG. Effects of an encapsulated fruit and vegetable juice concentrate on obesity-induced systemic inflammation: a randomised controlled trial. Nutrients. 2017;9(2):116. .

  449. Compton P, Griffis C, Breen EC, Torrington M, Sadakane R, Tefera E, Irwin MR. Opioid treatment of experimental pain activates nuclear factor-KB. J Opioid Manag. 2015 Mar-Apr;11(2):115-25. .

  450. Simmen S, Cosin-Roger J, Melhem H, Maliachovas N, Maane M, Baebler K, Weder B, Maeyashiki C, Spanaus K, Scharl M, de Valliere C, Zeitz J, Vavricka SR, Hausmann M, Rogler G, Ruiz PA. Iron prevents hypoxia-associated inflammation through the regulation of nuclear factor-KB in the intestinal epithelium. Cell Mol Gastroenterol Hepatol. 2019;7(2):339-55. .

  451. McKinley-Barnard SK, Andre TL, Gann JJ, Hwang PS, Willoughby DS. Effectiveness of fish oil supplementation in attenuating exercise-induced muscle damage in women during midfollicular and midluteal menstrual phases. J Strength Cond Res. 2018;32(6):1601-12. .

  452. Min S, Park SY, Yoon JY, Suh DH. Comparison of fractional microneedling radiofrequency and bipolar radiofrequency on acne and acne scar and investigation of mechanism: comparative randomized controlled clinical trial. Arch Dermatol Res. 2015;307(10):897-904. .

  453. Kuebler U, Arpagaus A, Meister RE, Von Kanel R, Huber S, Ehlert U, Wirtz PH. Dark chocolate attenuates intra-cellular pro-inflammatory reactivity to acute psychosocial stress in men: a randomized controlled trial. Brain Behav Immun. 2016;57:200-8. .

  454. Romeu M, Rubio L, Sanchez-Martos V, Castaner O, de la Torre R, Valls RM, Ras R, Pedret A, Catalan U, Lopez de las Hazas Mdel C, Motilva MJ, Fito M, Sola R, Giralt M. Virgin olive oil enriched with its own phenols or complemented with thyme phenols improves DNA pro-tection against oxidation and antioxidant enzyme activity in hyperlipidemic subjects. J Agric Food Chem. 2016 Mar 9;64(9):1879-88. .

  455. Navarro SL, White E, Kantor ED, Zhang Y, Rho J, Song X, Milne GL, Lampe PD, Lampe JW. Randomized trial of glucosamine and chondroitin supplementation on in-flammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. PLoS One. 2015 Feb 26;10(2):e0117534. .

  456. Aryaeian N, Shahram F, Mahmoudi M, Tavakoli H, Yousefi B, Arablou T, Jafari Karegar S. The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active rheumatoid arthritis. Gene. 2019 May 25;698:179-85. .

  457. Zhang G, Xia F, Zhang Y, Zhang X, Cao Y, Wang L, Liu X, Zhao G, Shi M. Ginsenoside Rd is efficacious against acute ischemic stroke by suppressing microglial proteasome-mediated inflammation. Mol Neurobiol. 2016 May;53(4):2529-40. .

  458. Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate. 2015 Apr 1;75(5):550-9. .

  459. Li Z, Wong A, Henning SM, Zhang Y, Jones A, Zerlin A, Thames G, Bowerman S, Tseng CH, Heber D. Hass avocado modulates postprandial vascular reactivity and post-prandial inflammatory responses to a hamburger meal in healthy volunteers. Food Fund 2013 Feb 26;4(3):384-91. .

  460. Sun L, Zhao L, Li P, Liu X, Liang F, Jiang Y, Kang N, Gao C, Yang J. Effect of hyperbaric oxygen therapy on HMGB1/NF-KB expression and prognosis of acute spinal cord injury: a randomized clinical trial. Neurosci Lett. 2019 Jan 23;692:47-52. .

  461. Parvaresh Rizi E, Baig S, Shabeer M, Teo Y, Mok SF, Loh TP, Magkos F, Virtue S, Vidal-Puig A, Tai ES, Khoo CM, Toh SA. Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity. Nutr J. 2016 Dec 1;15(1):100. .

  462. Kaur S, Kizoulis M, Fantasia J, Oddos T, Bigot N, Galera P, Tucker-Samaras S, Leyden JJ, Southall MD. 4-Hexyl-1,3-phenylenediol, a nuclear factor-KB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial. Br J Dermatol. 2015 Jul;173(1):218-26. .

  463. Roure R, Nollent V, Dayan L, Camel E, Bertin C. A dou-ble-blind, 12-week study to evaluate the antiaging efficacy of a cream containing the NFKB inhibitor 4-hexyl-1, 3-phenylenediol and ascorbic acid-2 glucoside in adult females. J Drugs Dermatol. 2016;15(6):750-8. .

  464. Herman SE, Mustafa RZ, Gyamfi JA, Pittaluga S, Chang S, Chang B, Farooqui M, Wiestner A. Ibrutinib inhibits BCR and NF-KB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL. Blood. 2014 May 22;123(21):3286-95. .

  465. Ishikawa K, Ishikawa J. Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-KB and production of RANKL: its efficacy, radio-graphic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients. Mod Rheumatol. 2019;29(3):418-29. .

  466. Zhou Y, Xu F, Deng H, Bi Y, Sun W, Zhao Y, Chen Z, Weng J. PEDF Expression is inhibited by insulin treatment in adipose tissue via suppressing 11p-HSD1. PLoS One. 2013 Dec 18;8(12):e84016. .

  467. Subramaniam K, Fallon K, Ruut T, Lane D, McKay R, Shadbolt B, Ang S, Cook M, Platten J, Pavli P, Taupin D. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease. Aliment Pharmacol Ther. 2015 Mar;41(5):419-28. .

  468. Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminski MS, Phillips T, Devata S, Mayer T, Wilcox RA. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. Am J Hematol. 2017 Dec;92(12):1287-94. .

  469. Pei R, DiMarco DM, Putt KK, Martin DA, Gu Q, Chitchumroonchokchai C, White HM, Scarlett CO, Bruno RS, Bolling BW. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial. Br J Nutr. 2017 Dec;118(12):1043-51. .

  470. Yehia R, Saleh S, El Abhar H, Saad AS, Schaalan M. L-Carnosine protects against oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a perspective on targeting Nrf-2 and NF-KB pathways. Toxicol Appl Pharmacol. 2019;365:41-50. .

  471. Liu X, Huang J, Li J, Mao Q, He J. Effects of liraglutide combined with insulin on oxidative stress and serum MCP-1 and NF-KB levels in type 2 diabetes. J Coll Physicians Surg Pak. 2019;29(3):218-21. .

  472. Crane JD, Ogborn DI, Cupido C, Melov S, Hubbard A, Bourgeois JM, Tarnopolsky MA. Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. Sci Transl Med. 2012;4(119):119ra13. .

  473. Creswell JD, Irwin MR, Burklund LJ, Lieberman MD, Arevalo JM, Ma J, Breen EC, Cole SW. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun. 2012 Oct;26(7):1095-101. .

  474. Camargo A, Delgado-Lista J, Garcia-Rios A, Cruz-Teno C, Yubero-Serrano EM, Perez-Martinez P, Gutierrez-Mariscal FM, Lora-Aguilar P, Rodriguez-Cantalejo F, Fuentes-Jimemez F, Tinahones FJ, Malagon MM, Perez-Jimenez F, Lopez-Miranda J. Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people. Br J Nutr. 2012;108(3):500-8. .

  475. Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK, Viollet B, Sakamoto K, Fagerholm SC, Foretz M, Lang CC, Rena G. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016 Aug 19;119(5):652-65. .

  476. Black DS, O'Reilly GA, Olmstead R, Breen EC, Irwin MR. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Intern Med. 2015;175(4):494-501. .

  477. Masuki S, Nishida K, Hashimoto S, Morikawa M, Takasugi S, Nagata M, Taniguchi S, Rokutan K, Nose H. Effects of milk product intake on thigh muscle strength and NFKB gene methylation during home-based interval walking training in older women: a randomized, controlled pilot study. PLoS One. 2017 May 17;12(5):e0176757. .

  478. Draganidis D, Chondrogianni N, Chatzinikolaou A, Ter- zis G, Karagounis LG, Sovatzidis A, Avloniti A, Lefaki M, Protopapa M, Deli CK, Papanikolaou K, Jamurtas AZ, Fatouros IG. Protein ingestion preserves proteasome ac-tivity during intense aseptic inflammation and facilitates skeletal muscle recovery in humans. Br J Nutr. 2017 Aug;118(3):189-200. .

  479. Michailidis Y, Karagounis LG, Terzis G, Jamurtas AZ, Spengos K, Tsoukas D, Chatzinikolaou A, Mandalidis D, Stefanetti RJ, Papassotiriou I, Athanasopoulos S, Hawley JA, Russell AP, Fatouros IG. Thiol-based anti-oxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am J Clin Nutr. 2013;98(1):233-45. .

  480. Hong DS, Henary H, Falchook GS, Naing A, Fu S, Moulder S, Wheler JJ, Tsimberidou A, Durand JB, Khan R, Yang P, Johansen M, Newman RA, Kurzrock R. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, NF-KB and p70s6k, in patients with advanced solid tumors. Invest New Drugs. 2014 Dec;32(6):1204-12. .

  481. Daak AA, Elderdery AY, Elbashir LM, Mariniello K, Mills J, Scarlett G, Elbashir MI, Ghebremeskel K. Omega 3 (n-3) fatty acids down-regulate nuclear factor-KB (NF-KB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease. Blood Cells Mol Dis. 2015 Jun;55(1):48-55. .

  482. Wolfle U, Hoffmann J, Haarhaus B, Rao Mittapalli V, Schempp CM. Anti-inflammatory and vasoconstrictive properties of Potentilla erecta-a traditional medicinal plant from the northern hemisphere. J Ethnopharmacol. 2017;204:86-94. .

  483. Sohrab G, Nasrollahzadeh J, Tohidi M, Zand H, Nikpayam O. Pomegranate juice increases sirtuin1 protein in peripheral blood mononuclear cell from patients with type 2 diabetes: a randomized placebo controlled clinical trial. Metab Syndr Relat Disord. 2018;16(8):446-51. .

  484. Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, Kerkoutian S, Wu H, Li Y, Creel P, Mundy K, Gurganus R, Fedor H, King SA, Zhang Y, Heber D, Pantuck AJ. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res (Phila). 2013 Oct;6(10):1120-7. .

  485. Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosia P, Sheyman M. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag. 2012;8:187-95. .

  486. Bhateja P, Dowlati A, Sharma N. Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer. Invest New Drugs. 2018;36(3):435-41. .

  487. Wang D, Wang YP, Cheng M, Cheng W, Hu SJ, Lv Y, We L, Jin H, Wang LY, Ren KJ. Intervention of qingshen granule on NF-KB signal pathway of chronic renal failure patients with damp-heat syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017 Jan;37(1):23-7. .

  488. Sun YL, Hou T, Liu SF, Zhang ZL, Zhang N, Yao M, Yang L, Shi Q, Cui XJ, Wang YJ. Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial. Trials. 2015 Feb 26;16:64. .

  489. Jablonski KL, Donato AJ, Fleenor BS, Nowlan MJ, Walker AE, Kaplon RE, Ballak DB, Seals DR. Reduced large elastic artery stiffness with regular aerobic exercise in middle-aged and older adults: potential role of suppressed nuclear factor KB signalling. J Hypertens. 2015 Dec;33(12):2477-82. .

  490. Abreu CC, Cardozo LFMF, Stockler-Pinto MB, Esgalhado M, Barboza JE, Frauches R, Mafra D. Does resistance exercise performed during dialysis modulate Nrf2 and NF-KB in patients with chronic kidney disease? Life Sci. 2017 Nov 1;188:192-7. .

  491. Saldanha JF, Leal VO, Rizzetto F, Grimmer GH, Ribeiro-Alves M, Daleprane JB, Carraro-Eduardo JC, Mafra D. Effects of resveratrol supplementation in Nrf2 and NF-KB expressions in nondialyzed chronic kidney disease patients: a randomized, double-blind, placebo-controlled, crossover clinical trial. J Ren Nutr. 2016 Nov; 26(6):401-6. .

  492. Abaza Y, Hidalgo-Lopez JE, Verstovsek S, Jabbour E, Ravandi F, Borthakur G, Estrov Z, Alvarado Y, Burger J, Schneider H, Soltysiak KA, Wei Y, Kantarjian HM, Bueso-Ramos CE, Garcia-Manero G. Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-KB activation. Leuk Res. 2018 Oct;73: 78-85. .

  493. Goldfine AB, Conlin PR, Halperin F, Koska J, Permana P, Schwenke D, Shoelson SE, Reaven PD. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia. 2013 Apr;56(4):714-23. .

  494. Giorgi VS, Peracoli MT, Peracoli JC, Witkin SS, Bannwart-Castro CF. Silibinin modulates the NF-KB pathway and proinflammatory cytokine production by mononuclear cells from preeclamptic women. J Reprod Immunol. 2012;95(1-2):67-72. .

  495. Van der Meij E, Koning GG, Vriens PW, Peeters MF, Meijer CA, Kortekaas KE, Dalman RL, van Bockel JH, Hanemaaijer R, Kooistra T, Kleemann R, Lindeman JH. A clinical evaluation of statin pleiotropy: Statins selectively and dose-dependently reduce vascular inflammation. PLoS One. 2013;8(1):e53882. .

  496. Klimek VM, Dolezal EK, Smith L, Soff G, Nimer SD. Phase I trial of sodium salicylate in patients with myelo-dysplastic syndromes and acute myelogenous leukemia. Leuk Res. 2012;36(5):570-74. .

  497. de Weerd A, Kho M, Kraaijeveld R, Zuiderwijk J, Weimar W, Baan C. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function. Clin Exp Immunol. 2014;175(2):296-304. doi:10.1111/cei.12225. .

  498. Tabit CE, Holbrook M, Shenouda SM, Dohadwala MM, Widlansky ME, Frame AA, Kim BH, Duess MA, Kluge MA, Levit A, Keany Jr JF, Vita JA, Hamburg NM. Effect of sulfasalazine on inflammation and endothelial function in patients with established coronary artery disease. Vasc Med. 2012;17(2):101-7. .

  499. Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, Arevalo JM, Ma J, Nicassio P, Ganz PA, Bower JE, Cole S. Tai Chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: A randomized controlled trial. J Natl Cancer Inst Monogr. 2014 Nov;2014(50):295-301. .

  500. Urban RJ, Dillon EL, Choudhary S, Zhao Y, Horstman AM, Tilton RG, Sheffield-Moore M. Translational studies in older men using testosterone to treat sarcopenia. Trans Am Clin Climatol Assoc. 2014;125:27-42. .

  501. Odia Y, Kreisl TN, Aregawi D, Innis EK, Fine HA. A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas. J Neurooncol. 2015; 125(1):191-5. .

  502. Peng S, Huo X, Rezaei D, Zhang Q, Zhang X, Yu C, Asanuma K, Cheng E, Pham TH, Wang DH, Chen M, Souza RF, Spechler SJ. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G129-39. .

  503. Wu F, Wang HY, Cai F, Wang LJ, Zhang FR, Chen XN, Yang Q, Jiang MH, Wang XF, Shen WF. Valsartan de-creases platelet activity and arterial thrombotic events in elderly patients with hypertension. Chin Med J (Engl). 2015 Jan 20;128(2):153-8. .

  504. Abdel-Latif MMM, Babar M, Kelleher D, Reynolds JV. A pilot study of the impact of vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. J Cancer Res Ther. 2019;15(1):185-91. .

  505. Mousa A, Naderpoor N, Johnson J, Sourris K, de Courten MPJ, Wilson K, Scragg R, Plebanski M, de Courten B. Effect of vitamin D supplementation on inflammation and nuclear factor K-B activity in overweight/obese adults: a randomized placebo-controlled trial. Sci Rep. 2017 Nov 9;7(1):15154. .

  506. Dihingia A, Ozah D, Baruah PK, Kalita J, Manna P. Pro-phylactic role of vitamin K supplementation on vascular inflammation in type 2 diabetes by regulating the NF-KB/ Nrf2 pathway via activating Gla proteins. Food Funct. 2018;9(1):450-62. .

  507. Merra G, Gratteri S, De Lorenzo A, Barrucco S, Perrone MA, Avolio E, Bernardini S, Marchetti M, Di Renzo L. Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):329-45. .

  508. Tan B, Liu J, Zhang PH, Fang L, Zhu FB. Effect of xinfeng capsule in improving blood stasis state of OA patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36(12):1449-55. .

  509. Zhu FB, Liu J, Fang L, Zhang PH, Tan B. Efficacy observation of xinfeng capsule for treating 58 cases of Sjogren's syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36(11):1323-8. .

  510. Zhu F, Liu J, Wang G, Fang L, Zhang P, Tan B. Xinfeng capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/ NF-KB signaling pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32(10):1366-71. .

  511. Fang L, Liu J, Zhu FB. Effect of xinfeng capsule on related factors of thrombus formation and inflammatory cytokines in active ankylosing spondylitis patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36(10):1202-7. .

  512. Zhang PH, Liu J, Tan B, Wan L. Xinfeng capsule improved blood stasis state of rheumatoid arthritis patients based on Actl/NF-KB signaling pathway: mechanism and effects. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016; 36(8):922-8. .

  513. Liu J, Qi Y, Zheng L, Cao Y, Wan L, Ye W, Fang L. Xin-feng capsule improves pulmonary function in ankylosing spondylitis patients via NF-KB-iNOS-NO signalling path-way. J Tradit Chin Med. 2014 Dec;34(6):657-65. .

  514. Mo XJ, Ye XZ, Li YP. Effects of euphorbia kansui on the serum levels of IL-6, TNF-a, NF-KB, sTNFR and IL-8 in patients with severe acute pancreatitis. J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2):469-75. .

  515. Abdel-Latif MMM, Babar M, Kelleher D, Reynolds JV. A pilot study of the impact of vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. J Cancer Res Ther. 2019 Jan-Mar;15(1):185-91. .

  516. Wang J, Hong Z, Wang N, Wu L, Ding B, Ge Z, Bi Y, Li W. Effects of a dietary supplement on inflammatory marker expression in middle-aged and elderly hypertensive patients. Clinics (Sao Paulo). 2019 Apr 8;74:e890. .

によって引用された
  1. Srinivasan Krishnapura, Anti-Inflammatory Influences of Culinary Spices and Their Bioactives, Food Reviews International, 2020. Crossref

  2. Parama Dey, Boruah Monikongkona, Yachna Kumari, Rana Varsha, Banik Kishore, Harsha Choudhary, Thakur Krishan Kumar, Dutta Uma, Arya Aditya, Mao Xinliang, Ahn Kwang Seok, Kunnumakkara Ajaikumar B., Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases, Life Sciences, 260, 2020. Crossref

  3. Yapasert Rittibet, Lertprasertsuk Nirush, Subhawa Subhawat, Poofery Juthathip, Sripanidkulchai Bungorn, Banjerdpongchai Ratana, Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo, International Journal of Molecular Sciences, 21, 16, 2020. Crossref

  4. Girisa Sosmitha, Parama Dey, Harsha Choudhary, Banik Kishore, Kunnumakkara Ajaikumar B., Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer, Exploration of Targeted Anti-tumor Therapy, 1, 5, 2020. Crossref

  5. Surai Peter F., Kochish Ivan I., Kidd Michael T., Redox Homeostasis in Poultry: Regulatory Roles of NF-κB, Antioxidants, 10, 2, 2021. Crossref

  6. Morein Dina, Rubinstein-Achiasaf Linor, Brayer Hadar, Dorot Orly, Pichinuk Edward, Ben-Yaakov Hagar, Meshel Tsipi, Pasmanik-Chor Metsada, Ben-Baruch Adit, Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells, Cells, 10, 6, 2021. Crossref

  7. Gilmore Thomas D., NF-κB and Human Cancer: What Have We Learned over the Past 35 Years?, Biomedicines, 9, 8, 2021. Crossref

  8. Ji Hongxia, Ma Junxia, Guo Lianjun, Huang Yongmei, Wang Weihong, Sun Xiuyan, Sun Rongchun, Amino acid sequence identification of goji berry cyclic peptides and anticervical carcinoma activity detection, Journal of Peptide Science, 27, 8, 2021. Crossref

  9. Onoshima Daisuke, Baba Yoshinobu, Cancer diagnosis and analysis devices based on multimolecular crowding, Chemical Communications, 57, 100, 2021. Crossref

  10. Zhang Changrong, Huang Yongquan, Li Peiwu, Chen Xinlin, Liu Fengbin, Hou Qiuke, Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction, BMC Complementary Medicine and Therapies, 20, 1, 2020. Crossref

  11. Fan Yingchao, Li Zhumeng, Wu Liting, Lin Feng, Shao Jinfeng, Ma Xiaoyan, Yao Yonghua, Zhuang Wenfang, Wang Yuan, Solasodine, Isolated from Solanum sisymbriifolium Fruits, Has a Potent Anti-Tumor Activity Against Pancreatic Cancer, Drug Design, Development and Therapy, Volume 15, 2021. Crossref

  12. Parama Dey, Rana Varsha, Girisa Sosmitha, Verma Elika, Daimary Uzini Devi, Thakur Krishan Kumar, Kumar Aviral, Kunnumakkara Ajaikumar B., The promising potential of piperlongumine as an emerging therapeutics for cancer, Exploration of Targeted Anti-tumor Therapy, 2021. Crossref

  13. Zhuo Yeye, Cai De, Chen Juntian, Zhang Qian, Li Xinxin, Pre-surgical peripheral blood inflammation markers predict surgical site infection following mesh repair of groin hernia, Medicine, 100, 9, 2021. Crossref

  14. Alharbi Khalid Saad, Fuloria Neeraj Kumar, Fuloria Shivkanya, Rahman Sk Batin, Al-Malki Waleed Hassan, Javed Shaikh Mohammad Arshad, Thangavelu Lakshmi, Singh Sachin K., Rama Raju Allam Venkata Sita, Jha Niraj Kumar, Chellappan Dinesh Kumar, Dua Kamal, Gupta Gaurav, Nuclear factor-kappa B and its role in inflammatory lung disease, Chemico-Biological Interactions, 345, 2021. Crossref

  15. Wang Anqi, Liu Jiayu, Yang Yuhan, Chen Zhejie, Gao Caifang, Wang Zhanguo, Fu Chaomei, Zou Liang, Wang Shengpeng, Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells, Chinese Medicine, 16, 1, 2021. Crossref

  16. Hsieh Shu-Ling, Shih Yi-Wen, Chiu Ying-Ming, Tseng Shao-Feng, Li Chien-Chun, Wu Chih-Chung, By-Products of the Black Soybean Sauce Manufacturing Process as Potential Antioxidant and Anti-Inflammatory Materials for Use as Functional Foods, Plants, 10, 12, 2021. Crossref

  17. Bhat Smitha S., Prasad Shashanka K., Shivamallu Chandan, Prasad Kollur Shiva, Syed Asad, Reddy Pruthvish, Cull Charley A., Amachawadi Raghavendra G., Genistein: A Potent Anti-Breast Cancer Agent, Current Issues in Molecular Biology, 43, 3, 2021. Crossref

  18. Banik Kishore, Khatoon Elina, Hegde Mangala, Thakur Krishan Kumar, Puppala Eswara Rao, Naidu V.G.M., Kunnumakkara Ajaikumar B., A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis, Life Sciences, 287, 2021. Crossref

  19. Pandey Manoj K, Von Suskil Max, Chitren Robert, Al-Odat Omar, Jonnalagadda Subash C., Aggarwal Bharat B., Cancer on fire: role of inflammation in prevention and treatment, in Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress, 2022. Crossref

  20. Kunnumakkara Ajaikumar B., Rana Varsha, Parama Dey, Banik Kishore, Girisa Sosmitha, Henamayee Sahu, Thakur Krishan Kumar, Dutta Uma, Garodia Prachi, Gupta Subash C., Aggarwal Bharat B., COVID-19, cytokines, inflammation, and spices: How are they related?, Life Sciences, 284, 2021. Crossref

  21. Girisa Sosmitha, Saikia Queen, Bordoloi Devivasha, Banik Kishore, Monisha Javadi, Daimary Uzini Devi, Verma Elika, Ahn Kwang Seok, Kunnumakkara Ajaikumar B., Xanthohumol from Hop: Hope for cancer prevention and treatment, IUBMB Life, 73, 8, 2021. Crossref

  22. Sharifi-Rad Javad, Quispe Cristina, Imran Muhammad, Rauf Abdur, Nadeem Muhammad, Gondal Tanweer Aslam, Ahmad Bashir, Atif Muhammad, Mubarak Mohammad S., Sytar Oksana, Zhilina Oxana Mihailovna, Garsiya Ekaterina Robertovna, Smeriglio Antonella, Trombetta Domenico, Pons Daniel Gabriel, Martorell Miquel, Cardoso Susana M., Razis Ahmad Faizal Abdull, Sunusi Usman, Kamal Ramla Muhammad, Rotariu Lia Sanda, Butnariu Monica, Docea Anca Oana, Calina Daniela, Toan Sam, Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits, Oxidative Medicine and Cellular Longevity, 2021, 2021. Crossref

  23. Malik Safiya, Singh Amardeep, Negi Poonam, Kapoor Vijay Kumar, Thymoquinone: A small molecule from nature with high therapeutic potential, Drug Discovery Today, 26, 11, 2021. Crossref

  24. Daimary Uzini Devi, Parama Dey, Rana Varsha, Banik Kishore, Kumar Aviral, Harsha Choudhary, Kunnumakkara Ajaikumar B., Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases, Current Research in Pharmacology and Drug Discovery, 2, 2021. Crossref

  25. Soofiyani Saiedeh Razi, Hosseini Kamran, Forouhandeh Haleh, Ghasemnejad Tohid, Tarhriz Vahideh, Asgharian Parina, Reiner Željko, Sharifi-Rad Javad, Cho William C., Gil German, Quercetin as a Novel Therapeutic Approach for Lymphoma, Oxidative Medicine and Cellular Longevity, 2021, 2021. Crossref

  26. Ortega Joseph Thomas, Jastrzebska Beata, Neuroinflammation as a Therapeutic Target in Retinitis Pigmentosa and Quercetin as Its Potential Modulator, Pharmaceutics, 13, 11, 2021. Crossref

  27. Zhang Yang, Ni Weixing, Qin Lei, RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition, Aging, 13, 17, 2021. Crossref

  28. James Shirley, Aparna Jayasekharan S., Babu Anu, Paul Aswathy Mary, Lankadasari Manendra Babu, Athira Subha R., Kumar Sreesha S., Vijayan Yadu, Namitha Narayanan N., Mohammed Sabira, Reshmi Girijadevi, Harikumar Kuzhuvelil B., Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer, Biomolecules, 11, 5, 2021. Crossref

  29. Thakur Krishan K., Kumar Aviral, Banik Kishore, Verma Elika, Khatoon Elina, Harsha Choudhary, Sethi Gautam, Gupta Subash C., Kunnumakkara Ajaikumar B., Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis, Journal of Cellular Physiology, 236, 12, 2021. Crossref

  30. Li Yanchu, Pu Rong, Zhou Lu, Wang Dan, Li Xianyong, Malfa Giuseppe, Effects of a Chlorogenic Acid-Containing Herbal Medicine (LASNB) on Colon Cancer, Evidence-Based Complementary and Alternative Medicine, 2021, 2021. Crossref

  31. Farhadnejad Hossein, Tehrani Asal Neshatbini, Jahromi Mitra Kazemi, Teymoori Farshad, Mokhtari Ebrahim, Salehi-Sahlabadi Ammar, Mirmiran Parvin, The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults, BMC Gastroenterology, 22, 1, 2022. Crossref

  32. Wang Huanan, Guo Feng, Wang Min, Wang Tingting, Wang Shanzhi, Huang Yanni, Ye Feng, Dong Zhaoqi , The Effect of TLR9, MyD88, and NF-κB p65 in Systemic Lupus Erythematosus, Evidence-Based Complementary and Alternative Medicine, 2022, 2022. Crossref

  33. Singh Anuj Kumar, Roy Nand Kishor, Bordoloi Devivasha, Padmavathi Ganesan, Banik Kishore, Khwairakpam Amrita Devi, Kunnumakkara Ajaikumar B., Sukumar Piruthivi, Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF-κB signalling, Life Sciences, 261, 2020. Crossref

  34. Gupta Manish Kumar, Senthilkumar Sanjana, Chiranjivi Adarsh Kumar, Banik Kishore, Girisa Sosmitha, Kunnumakkara Ajaikumar Bahulayan, Dubey Vikash Kumar, Rangan Latha, Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3,5-dihydroxy-4′,7-dimethoxyflavone isolated from the leaves of Alpinia nigra, Phytomedicine Plus, 1, 3, 2021. Crossref

  35. Dorothy VanderJagt, Lucy Hunsaker, Sunday O. Otimenyin, Mary O. Uguru, The anti-inflammatory activities of twelve Nigerian medicinal plants: Inhibition of NfkB, activation of Nrf2, and antioxidant content, African Journal of Biochemistry Research, 16, 1, 2022. Crossref

  36. Mueller Anna-Lena, Brockmueller Aranka, Kunnumakkara Ajaikumar B., Shakibaei Mehdi, Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis, Nutrients, 14, 10, 2022. Crossref

  37. Yao Huixiang, Yan Jun, Yin Li, Chen Wei, Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway, Immunopharmacology and Immunotoxicology, 44, 3, 2022. Crossref

  38. Daimary Uzini, Girisa Sosmitha, Parama Dey, Verma Elika, Kumar Aviral, Kunnumakkara Ajaikumar B., Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases, Journal of Biochemical and Molecular Toxicology, 36, 2, 2022. Crossref

  39. Ma Xiaoping, Okyere Samuel Kumi, Hu Liwen, Wen Juan, Ren Zhihua, Deng Junliang, Hu Yanchun, Anti-Inflammatory Activity and Mechanism of Cryptochlorogenic Acid from Ageratina adenophora, Nutrients, 14, 3, 2022. Crossref

  40. Kumar Aviral, Harsha Choudhary, Parama Dey, Girisa Sosmitha, Daimary Uzini Devi, Mao Xinliang, Kunnumakkara Ajaikumar B., Current clinical developments in curcumin‐based therapeutics for cancer and chronic diseases, Phytotherapy Research, 35, 12, 2021. Crossref

  41. Shen Xiaoyi, Tan Sasa, Feng Xianzhen, Fu Wenzhen, Hu Yunqiu, Li Miao, Wang Wenjie, Yuan Hu, Liu Li, Wang Chun, Hua Fei, Alias Ekram, Association between NF-κB Signal Pathway-Related Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density, Evidence-Based Complementary and Alternative Medicine, 2022, 2022. Crossref

  42. He Fanghan, Cheng Qi, Li Na, Shang Yunxiao, Carbenoxolone Ameliorates Allergic Airway Inflammation through NF-κB/NLRP3 Pathway in Mice, Biological and Pharmaceutical Bulletin, 45, 6, 2022. Crossref

  43. Yuan Meng, Zhang Guoqing, Bai Weijun, Han Xin, Li Chan, Bian Siman, Qin Si, The Role of Bioactive Compounds in Natural Products Extracted from Plants in Cancer Treatment and Their Mechanisms Related to Anticancer Effects, Oxidative Medicine and Cellular Longevity, 2022, 2022. Crossref

  44. Li Yonglu, Wang Yaxuan, Yu Xin, Yu Ting, Zheng Xiaodong, Chu Qiang, Radix Tetrastigma Inhibits the Non-Small Cell Lung Cancer via Bax/Bcl-2/Caspase-9/Caspase-3 Pathway, Nutrition and Cancer, 74, 1, 2022. Crossref

  45. Bai Donghui, Sun Tianxiao, Lu Fang, Shen Yancheng, Zhang Yan, Zhang Bo, Yu Guangli, Li Haihua, Hao Jiejie, Eupatilin Suppresses OVA-Induced Asthma by Inhibiting NF-κB and MAPK and Activating Nrf2 Signaling Pathways in Mice, International Journal of Molecular Sciences, 23, 3, 2022. Crossref

  46. Tan Bingyi, Yuan Zenong, Zhang Qingyu, Xiqiang Xu, Dong Jun, The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells, Journal of Applied Biomedicine, 19, 4, 2021. Crossref

  47. Parama Dey, Girisa Sosmitha, Khatoon Elina, Kumar Aviral, Alqahtani Mohammed S., Abbas Mohamed, Sethi Gautam, Kunnumakkara Ajaikumar B., An overview of the pharmacological activities of scopoletin against different chronic diseases, Pharmacological Research, 179, 2022. Crossref

  48. Liu Zejin, Niu Xinli, Wang Junpeng, Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study, Critical Reviews in Food Science and Nutrition, 2022. Crossref

  49. Banik Kishore, Khatoon Elina, Harsha Choudhary, Rana Varsha, Parama Dey, Thakur Krishan Kumar, Bishayee Anupam, Kunnumakkara Ajaikumar B., Wogonin and its analogs for the prevention and treatment of cancer: A systematic review, Phytotherapy Research, 36, 5, 2022. Crossref

  50. Zheng J., Wang J., Liu H., Chen F., Wang H., Chen S., Xie J., Zheng Z., Li Z., Alarmins S100A8/A9 promote intervertebral disc degeneration and inflammation-related pain in a rat model through toll-like receptor-4 and activation of the NF-κB signaling pathway, Osteoarthritis and Cartilage, 30, 7, 2022. Crossref

  51. Yang Longhe, Hu Fan, Yan Yajun, Yu Siyu, Chen Tingting, Wang Zhaokai, Anti-Inflammatory Effect of Acetone Extracts from Microalgae Chlorella sp. WZ13 on RAW264.7 Cells and TPA-induced Ear Edema in Mice, Frontiers in Marine Science, 9, 2022. Crossref

  52. Ahmed Semim Akhtar, Parama Dey, Daimari Enush, Girisa Sosmitha, Banik Kishore, Harsha Choudhary, Dutta Uma, Kunnumakkara Ajaikumar B., Rationalizing the therapeutic potential of apigenin against cancer, Life Sciences, 267, 2021. Crossref

  53. Zhang Yanjun, Wang Chunli, Li Xiaona, Yang Li, TGF-β1 and Mechanical-Stretch Induction of Lysyl-Oxidase and Matrix-Metalloproteinase Expression in Synovial Fibroblasts Requires NF-κB Pathways, Processes, 10, 8, 2022. Crossref

  54. Khatoon Elina, Hegde Mangala, Kumar Aviral, Daimary Uzini Devi, Sethi Gautam, Bishyaee Anupam, Kunnumakkara Ajaikumar B., The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer, Archives of Pharmacal Research, 45, 8, 2022. Crossref

  55. Wang Tianyue, Zhou Yaqiong, Wang Kaina, Jiang Xinyu, Wang Jingbo, Chen Jing, Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology, Medicine, 101, 26, 2022. Crossref

  56. Martini Daniela, Marino Mirko, Venturi Samuele, Tucci Massimiliano, Klimis-Zacas Dorothy, Riso Patrizia, Porrini Marisa, Del Bo’ Cristian, Blueberries and their bioactives in the modulation of oxidative stress, inflammation and cardio/vascular function markers: a systematic review of human intervention studies, The Journal of Nutritional Biochemistry, 111, 2023. Crossref

  57. Venkat Ramya, Verma Elika, Daimary Uzini Devi, Kumar Aviral, Girisa Sosmitha, Dutta Uma, Ahn Kwang Seok, Kunnumakkara Ajaikumar B., The Journey of Resveratrol from Vineyards to Clinics, Cancer Investigation, 2022. Crossref

  58. Sajeev Anjana, Hegde Mangala, Girisa Sosmitha, Devanarayanan Thulasidharan Nair, Alqahtani Mohammed S., Abbas Mohamed, Sil Samir Kumar, Sethi Gautam, Chen Jen-Tsung, Kunnumakkara Ajaikumar B., Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases, Biomolecules, 12, 9, 2022. Crossref

  59. Wu Shujian, Liao Xiyu, Zhu Zhenjun, Huang Rui, Chen Mengfei, Huang Aohuan, Zhang Jumei, Wu Qingping, Wang Juan, Ding Yu, Antioxidant and anti-inflammation effects of dietary phytochemicals: The Nrf2/NF-κB signalling pathway and upstream factors of Nrf2, Phytochemistry, 204, 2022. Crossref

  60. Cheng Junfei, Sun Yuemei, He Jiaxin, Wang Zihan, Li Wenbin, Wang Rong, The mechanism of colon tissue damage mediated by HIF-1α/NF-κB/STAT1 in high-altitude environment, Frontiers in Physiology, 13, 2022. Crossref

  61. Wang Xing, Huan Yi, Liu Shuainan, Li Caina, Cao Hui, Lei Lei, Liu Quan, Ji Wenming, Sun Sujuan, Huang Kaixun, Zhou Jun, Shen Zhufang, Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells, International Journal of Molecular Sciences, 23, 19, 2022. Crossref

  62. Zhang Xiaogang, Zhang Mingming, Liu Yanqing, Wang Zhiqiang, Feng Xing, Liu Ning, Zhao Dongbao, Mishra Sandip K, Investigation on the Inhibitory Effect of Methotrexate on Rheumatoid Synovitis via the TLR4-NF-κB Pathway in a Rat Model, Contrast Media & Molecular Imaging, 2022, 2022. Crossref

  63. Petrichuk S. V., Radygina T. V., Kuptsova D. G., Kurbatova O. V., Semikina E. L., Murashkin N. N., Potapov A. S., Fisenko A. P., Evaluation of anti-TNF treatment efficiency in children with immune-dependent diseases by means of testing the NF-κB activity in lymphocyte populations, Russian Journal of Immunology, 25, 4, 2022. Crossref

近刊の記事

Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain